Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	TRPM4 DCHS2 FAT4 PCDHA9 REG4 MYO5A DSG3 ITLN1 PCDHGA3 FAT3 PCDHA7 PCDHA4 ADGRV1 PKD1L2 EHD4 FAT1 MICU3 ATP2C1 DST USP32 MACF1 PCDH9	2.25e-07	749	164	22	GO:0005509
GeneOntologyMolecularFunction	phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity	INPP4A INPP4B	6.70e-05	2	164	2	GO:0016316
GeneOntologyMolecularFunction	inositol-3,4-bisphosphate 4-phosphatase activity	INPP4A INPP4B	6.70e-05	2	164	2	GO:0052828
GeneOntologyMolecularFunction	inositol-1,3,4-trisphosphate 4-phosphatase activity	INPP4A INPP4B	6.70e-05	2	164	2	GO:0017161
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	ACTB ACTG1 POTEKP	8.55e-05	11	164	3	GO:0098973
GeneOntologyMolecularFunction	monoatomic ion-gated channel activity	TRPM4 TMEM63C KCNK18 KCNT2	1.16e-04	31	164	4	GO:0022839
GeneOntologyMolecularFunction	protein tyrosine kinase activity	FLT4 AXL YES1 AATK ROS1 FGR FYN	1.98e-04	145	164	7	GO:0004713
GeneOntologyMolecularFunction	protein phosphatase binding	FLT4 PPP1R3A IKBKE PIK3R2 ROS1 MAPK8 CABIN1 ANAPC4	3.52e-04	210	164	8	GO:0019903
GeneOntologyMolecularFunction	phosphatidylinositol-3,4-bisphosphate phosphatase activity	INPP4A INPP4B	3.98e-04	4	164	2	GO:0106017
GeneOntologyMolecularFunction	protein kinase activity	FLT4 ATR KALRN MARK3 AXL YES1 PIK3R4 AATK IKBKE RPS6KA6 ROS1 FGR MAPK8 FYN	4.45e-04	600	164	14	GO:0004672
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	ANK3 ACTB ACTG1 POTEKP ADD1 VILL	7.22e-04	130	164	6	GO:0005200
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	FLT4 ATR KALRN HYKK MARK3 AXL YES1 PIK3R4 AATK IKBKE RPS6KA6 ROS1 FGR MAPK8 FYN	7.67e-04	709	164	15	GO:0016773
GeneOntologyBiologicalProcess	cell-cell adhesion	DCHS2 FAT4 PCDHA9 ANK3 DSCAM DSG3 NLGN4Y PCDHGA3 FAT3 CELA2A ACTB ACTG1 PCDHA7 PCDHA4 WNT4 ADGRV1 YES1 LEP PDPN FAT1 ATP2C1 NLGN4X COL14A1 PLAUR FYN PCDH9 IL4R	9.47e-08	1077	163	27	GO:0098609
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 FAT4 PCDHA9 DSCAM DSG3 PCDHGA3 FAT3 PCDHA7 PCDHA4 FAT1 PCDH9	2.94e-07	187	163	11	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 FAT4 PCDHA9 DSCAM DSG3 PCDHGA3 FAT3 PCDHA7 PCDHA4 FAT1 ATP2C1 PCDH9	7.60e-06	313	163	12	GO:0098742
GeneOntologyBiologicalProcess	axonogenesis	ANK3 DSCAM SEMA7A KALRN UNC5B ACTB ACTG1 LAMC1 POTEKP ARHGAP35 DST FEZ2 TTL MACF1 FYN	4.49e-05	566	163	15	GO:0007409
GeneOntologyBiologicalProcess	integrin-mediated signaling pathway	SEMA7A LAMC1 ARHGAP35 DST DIAPH3 FGR MAPK8	5.87e-05	124	163	7	GO:0007229
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	ANK3 DSCAM SEMA7A KALRN UNC5B FAT3 ACTB ACTG1 LAMC1 POTEKP ARHGAP35 DST FEZ2 TTL MACF1 MAPK8 FYN	9.29e-05	748	163	17	GO:0048667
GeneOntologyBiologicalProcess	endocytosis	DNAJC13 ANK3 NLGN4Y AXL ACTB ACTG1 UNC13D USP46 YES1 DNAJC6 LEP ADD1 EHD4 SORT1 NLGN4X ACKR3 FGR FYN	9.91e-05	827	163	18	GO:0006897
GeneOntologyBiologicalProcess	import into cell	TRPM4 DNAJC13 ANK3 NLGN4Y AXL ACTB ACTG1 UNC13D USP46 YES1 DNAJC6 SLC1A7 LEP ADD1 EHD4 SORT1 NLGN4X ACKR3 FGR SLC12A7 FYN	1.16e-04	1074	163	21	GO:0098657
GeneOntologyBiologicalProcess	regulation of organelle organization	GPR3 TBC1D15 ATR MYO5A CTC1 CAPN6 ACTB ACTG1 WNT4 ARHGAP35 CLIP1 ADD1 LMAN1 VILL FEZ2 SLF2 SNX7 PIK3R2 CDK5RAP2 PLAUR DIAPH3 FGR MAPK8 ANAPC4	1.45e-04	1342	163	24	GO:0033043
GeneOntologyBiologicalProcess	wound healing	AXL CELA2A ACTB ACTG1 WNT4 ARHGAP35 PDPN DST LMAN1 FGF1 MACF1 PLAUR KNG1	1.54e-04	493	163	13	GO:0042060
GeneOntologyBiologicalProcess	axon development	ANK3 DSCAM SEMA7A KALRN UNC5B ACTB ACTG1 LAMC1 POTEKP ARHGAP35 DST FEZ2 TTL MACF1 FYN	1.81e-04	642	163	15	GO:0061564
GeneOntologyBiologicalProcess	cell morphogenesis	ANK3 DSCAM SEMA7A KALRN UNC5B FAT3 ACTB ACTG1 LAMC1 POTEKP ARHGAP35 ADD1 PDPN FRY FAT1 DST FEZ2 TTL MACF1 FGR MAPK8 FYN	1.85e-04	1194	163	22	GO:0000902
GeneOntologyBiologicalProcess	territorial aggressive behavior	NLGN4Y NLGN4X	1.85e-04	3	163	2	GO:0002124
GeneOntologyCellularComponent	actin cytoskeleton	DENND2A CALD1 MYO5A KALRN AXL RGS22 ACTB ACTG1 POTEKP ARHGAP35 YES1 ADD1 DST VILL MACF1 DIAPH3 FGR MAPK8 FYN	1.56e-07	576	165	19	GO:0015629
GeneOntologyCellularComponent	actin filament	CALD1 MYO5A ACTB ACTG1 POTEKP YES1 DIAPH3 FYN	2.13e-05	146	165	8	GO:0005884
GeneOntologyCellularComponent	asymmetric synapse	ANK3 KALRN NLGN4Y INPP4A DNAJC6 ADD1 SORT1 DST NLGN4X SCN8A MACF1 GRIP2 DGCR8 FYN	2.68e-05	477	165	14	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	ANK3 KALRN NLGN4Y INPP4A YES1 DNAJC6 ADD1 DST NLGN4X SCN8A MACF1 GRIP2 DGCR8 FYN	4.77e-05	503	165	14	GO:0099572
GeneOntologyCellularComponent	postsynapse	CALD1 ANK3 ATR MYO5A KALRN NLGN4Y INPP4A ACTB ACTG1 YES1 DNAJC6 SLC1A7 ADD1 SENP1 DST NLGN4X SCN8A MACF1 GRIP2 DGCR8 FYN	5.41e-05	1018	165	21	GO:0098794
GeneOntologyCellularComponent	postsynaptic density	ANK3 KALRN NLGN4Y INPP4A DNAJC6 ADD1 DST NLGN4X SCN8A MACF1 GRIP2 DGCR8 FYN	6.29e-05	451	165	13	GO:0014069
GeneOntologyCellularComponent	neuron to neuron synapse	ANK3 KALRN NLGN4Y INPP4A DNAJC6 ADD1 SORT1 DST NLGN4X SCN8A MACF1 GRIP2 DGCR8 FYN	7.24e-05	523	165	14	GO:0098984
GeneOntologyCellularComponent	external encapsulating structure	SEMA7A ITLN1 CELA2A LAMC1 CPA3 ADAMTS8 CELA2B WNT4 PKHD1L1 DST LMAN1 COL21A1 FGF1 COL14A1 KNG1	2.34e-04	658	165	15	GO:0030312
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4Y NLGN4X	3.68e-04	4	165	2	GO:0098983
GeneOntologyCellularComponent	postsynaptic actin cytoskeleton	MYO5A ACTB ACTG1	4.26e-04	19	165	3	GO:0098871
GeneOntologyCellularComponent	chromosome, telomeric region	RAD51D H2BW1 ATR CTC1 ZNF827 SLF2 LRIF1	5.07e-04	176	165	7	GO:0000781
GeneOntologyCellularComponent	keratohyalin granule	CELA2A CELA2B	6.10e-04	5	165	2	GO:0036457
GeneOntologyCellularComponent	anchoring junction	DCHS2 ANK3 DSG3 ACTB ACTG1 FBP2 MFRP YES1 ADD1 PDPN FAT1 SENP1 DST PIK3R2 PLAUR TNS4 ABCC2 PCDH9	7.23e-04	976	165	18	GO:0070161
GeneOntologyCellularComponent	extracellular matrix	SEMA7A ITLN1 CELA2A LAMC1 CPA3 ADAMTS8 CELA2B WNT4 DST LMAN1 COL21A1 FGF1 COL14A1 KNG1	7.26e-04	656	165	14	GO:0031012
GeneOntologyCellularComponent	asymmetric, glutamatergic, excitatory synapse	NLGN4Y SORT1 NLGN4X	8.65e-04	24	165	3	GO:0098985
GeneOntologyCellularComponent	supramolecular fiber	CALD1 ANK3 MYO5A CEP162 CAPN6 ACTB ACTG1 KLHL41 FBP2 POTEKP YES1 CLIP1 DST LMAN1 SCN8A TTL CDK5RAP2 MACF1 DIAPH3 FYN	1.03e-03	1179	165	20	GO:0099512
GeneOntologyCellularComponent	collagen-containing extracellular matrix	SEMA7A ITLN1 CELA2A LAMC1 CPA3 ADAMTS8 CELA2B DST LMAN1 COL21A1 COL14A1 KNG1	1.05e-03	530	165	12	GO:0062023
GeneOntologyCellularComponent	postsynaptic cytoskeleton	MYO5A ACTB ACTG1	1.10e-03	26	165	3	GO:0099571
GeneOntologyCellularComponent	supramolecular polymer	CALD1 ANK3 MYO5A CEP162 CAPN6 ACTB ACTG1 KLHL41 FBP2 POTEKP YES1 CLIP1 DST LMAN1 SCN8A TTL CDK5RAP2 MACF1 DIAPH3 FYN	1.12e-03	1187	165	20	GO:0099081
GeneOntologyCellularComponent	dense body	ACTB ACTG1	1.27e-03	7	165	2	GO:0097433
GeneOntologyCellularComponent	ruffle	MYO5A KLHL41 CLIP1 PDPN PLEKHA1 MACF1 FGR	1.28e-03	206	165	7	GO:0001726
GeneOntologyCellularComponent	microtubule plus-end	CLIP1 DST CDK5RAP2	1.37e-03	28	165	3	GO:0035371
GeneOntologyCellularComponent	myofibril	CALD1 ANK3 ACTG1 KLHL41 FBP2 DST LMAN1 SCN8A	1.50e-03	273	165	8	GO:0030016
GeneOntologyCellularComponent	perinuclear endoplasmic reticulum	DST DGAT2 FYN	1.52e-03	29	165	3	GO:0097038
GeneOntologyCellularComponent	stereocilia coupling link	ADGRV1 DIAPH3	1.68e-03	8	165	2	GO:0002139
GeneOntologyCellularComponent	chromosomal region	RAD51D H2BW1 ATR CENPC CTC1 ACTB CLIP1 ZNF827 SLF2 LRIF1	1.94e-03	421	165	10	GO:0098687
GeneOntologyCellularComponent	NuA4 histone acetyltransferase complex	ACTB ACTG1 POTEKP	2.02e-03	32	165	3	GO:0035267
GeneOntologyCellularComponent	H4/H2A histone acetyltransferase complex	ACTB ACTG1 POTEKP	2.02e-03	32	165	3	GO:0043189
GeneOntologyCellularComponent	glutamatergic synapse	CALD1 MYO5A KALRN NLGN4Y INPP4A ACTB USP46 YES1 SLC1A7 SORT1 NLGN4X SCN8A GRIP2 DGCR8 FYN	2.11e-03	817	165	15	GO:0098978
GeneOntologyCellularComponent	cell leading edge	MYO5A ACTB KLHL41 ADGRV1 CLIP1 PDPN FAT1 DST PLEKHA1 MACF1 FGR	2.12e-03	500	165	11	GO:0031252
GeneOntologyCellularComponent	contractile muscle fiber	CALD1 ANK3 ACTG1 KLHL41 FBP2 DST LMAN1 SCN8A	2.19e-03	290	165	8	GO:0043292
GeneOntologyCellularComponent	focal adhesion	ACTB ACTG1 YES1 ADD1 FAT1 SENP1 DST PIK3R2 PLAUR TNS4	2.29e-03	431	165	10	GO:0005925
GeneOntologyCellularComponent	extrinsic component of membrane	ATP6V1A ATR KALRN DNAJC6 PIK3R4 PIK3R2 PLAUR	2.38e-03	230	165	7	GO:0019898
GeneOntologyCellularComponent	cell-substrate junction	ACTB ACTG1 YES1 ADD1 FAT1 SENP1 DST PIK3R2 PLAUR TNS4	2.80e-03	443	165	10	GO:0030055
GeneOntologyCellularComponent	microtubule end	CLIP1 DST CDK5RAP2	3.33e-03	38	165	3	GO:1990752
GeneOntologyCellularComponent	centriolar satellite	CEP162 LHCGR TBC1D31 IL4R LRIF1	3.50e-03	128	165	5	GO:0034451
Domain	Cadherin_CS	DCHS2 FAT4 PCDHA9 DSG3 PCDHGA3 FAT3 PCDHA7 PCDHA4 FAT1 PCDH9	4.43e-08	109	165	10	IPR020894
Domain	CADHERIN_1	DCHS2 FAT4 PCDHA9 DSG3 PCDHGA3 FAT3 PCDHA7 PCDHA4 FAT1 PCDH9	6.26e-08	113	165	10	PS00232
Domain	Cadherin	DCHS2 FAT4 PCDHA9 DSG3 PCDHGA3 FAT3 PCDHA7 PCDHA4 FAT1 PCDH9	6.26e-08	113	165	10	PF00028
Domain	CADHERIN_2	DCHS2 FAT4 PCDHA9 DSG3 PCDHGA3 FAT3 PCDHA7 PCDHA4 FAT1 PCDH9	6.81e-08	114	165	10	PS50268
Domain	-	DCHS2 FAT4 PCDHA9 DSG3 PCDHGA3 FAT3 PCDHA7 PCDHA4 FAT1 PCDH9	6.81e-08	114	165	10	2.60.40.60
Domain	CA	DCHS2 FAT4 PCDHA9 DSG3 PCDHGA3 FAT3 PCDHA7 PCDHA4 FAT1 PCDH9	7.40e-08	115	165	10	SM00112
Domain	Cadherin-like	DCHS2 FAT4 PCDHA9 DSG3 PCDHGA3 FAT3 PCDHA7 PCDHA4 FAT1 PCDH9	8.04e-08	116	165	10	IPR015919
Domain	Cadherin	DCHS2 FAT4 PCDHA9 DSG3 PCDHGA3 FAT3 PCDHA7 PCDHA4 FAT1 PCDH9	9.46e-08	118	165	10	IPR002126
Domain	Kinase-like_dom	FLT4 ATR KALRN HYKK MARK3 AXL ARHGAP35 YES1 PIK3R4 AATK DST IKBKE RPS6KA6 MACF1 ROS1 FGR MAPK8 FYN	1.52e-06	542	165	18	IPR011009
Domain	PROTEIN_KINASE_TYR	FLT4 AXL YES1 AATK ROS1 FGR FYN	2.44e-05	97	165	7	PS00109
Domain	Tyr_kinase_AS	FLT4 AXL YES1 AATK ROS1 FGR FYN	2.44e-05	97	165	7	IPR008266
Domain	NLGN4	NLGN4Y NLGN4X	7.76e-05	2	165	2	IPR030025
Domain	FGR	YES1 FGR	7.76e-05	2	165	2	IPR028459
Domain	Tyr_kinase_cat_dom	FLT4 AXL YES1 ROS1 FGR FYN	1.29e-04	88	165	6	IPR020635
Domain	TyrKc	FLT4 AXL YES1 ROS1 FGR FYN	1.29e-04	88	165	6	SM00219
Domain	Pkinase_Tyr	FLT4 AXL YES1 AATK ROS1 FGR FYN	1.50e-04	129	165	7	PF07714
Domain	Laminin_G	FAT4 FAT3 FAT1 COL21A1 COL14A1	1.59e-04	58	165	5	IPR001791
Domain	-	FAT4 FAT3 ADGRV1 FAT1 LMAN1 COL21A1	1.97e-04	95	165	6	2.60.120.200
Domain	PROTEIN_KINASE_ATP	FLT4 KALRN MARK3 AXL YES1 PIK3R4 AATK IKBKE RPS6KA6 ROS1 FGR MAPK8 FYN	2.26e-04	459	165	13	PS00107
Domain	Ser-Thr/Tyr_kinase_cat_dom	FLT4 AXL YES1 AATK ROS1 FGR FYN	2.27e-04	138	165	7	IPR001245
Domain	Cadherin_2	PCDHA9 PCDHGA3 PCDHA7 PCDHA4 PCDH9	2.73e-04	65	165	5	PF08266
Domain	Cadherin_N	PCDHA9 PCDHGA3 PCDHA7 PCDHA4 PCDH9	2.73e-04	65	165	5	IPR013164
Domain	SH2	YES1 PIK3R2 DAPP1 TNS4 FGR FYN	2.75e-04	101	165	6	PF00017
Domain	Cadherin_tail	PCDHA9 PCDHGA3 PCDHA7 PCDHA4	3.09e-04	37	165	4	PF15974
Domain	Cadherin_CBD	PCDHA9 PCDHGA3 PCDHA7 PCDHA4	3.09e-04	37	165	4	IPR031904
Domain	Prot_kinase_dom	FLT4 KALRN MARK3 AXL YES1 PIK3R4 AATK IKBKE RPS6KA6 ROS1 FGR MAPK8 FYN	4.15e-04	489	165	13	IPR000719
Domain	SH2	YES1 PIK3R2 DAPP1 TNS4 FGR FYN	4.36e-04	110	165	6	SM00252
Domain	PROTEIN_KINASE_DOM	FLT4 KALRN MARK3 AXL YES1 PIK3R4 AATK IKBKE RPS6KA6 ROS1 FGR MAPK8 FYN	4.48e-04	493	165	13	PS50011
Domain	SH2	YES1 PIK3R2 DAPP1 TNS4 FGR FYN	4.57e-04	111	165	6	PS50001
Domain	Ubiquitin_3	USP32 USP15	4.60e-04	4	165	2	PF14836
Domain	Ub_USP-typ	USP32 USP15	4.60e-04	4	165	2	IPR028135
Domain	SH2	YES1 PIK3R2 DAPP1 TNS4 FGR FYN	4.80e-04	112	165	6	IPR000980
Domain	-	YES1 PIK3R2 DAPP1 TNS4 FGR FYN	4.80e-04	112	165	6	3.30.505.10
Domain	Protein_kinase_ATP_BS	FLT4 KALRN MARK3 AXL YES1 AATK IKBKE RPS6KA6 ROS1 FGR FYN	5.64e-04	379	165	11	IPR017441
Domain	Nlgn	NLGN4Y NLGN4X	7.62e-04	5	165	2	IPR000460
Domain	PI3kinase_P85	PIK3R2 DAPP1	7.62e-04	5	165	2	IPR001720
Domain	Spectrin	KALRN DST MACF1	1.05e-03	23	165	3	PF00435
Domain	-	DST MACF1	1.14e-03	6	165	2	3.90.1290.10
Domain	GAR	DST MACF1	1.14e-03	6	165	2	PS51460
Domain	DUSP	USP32 USP15	1.14e-03	6	165	2	PF06337
Domain	GAS2	DST MACF1	1.14e-03	6	165	2	PF02187
Domain	DUSP	USP32 USP15	1.14e-03	6	165	2	SM00695
Domain	-	DST MACF1	1.14e-03	6	165	2	3.30.920.20
Domain	GAS_dom	DST MACF1	1.14e-03	6	165	2	IPR003108
Domain	GAS2	DST MACF1	1.14e-03	6	165	2	SM00243
Domain	Plectin	DST MACF1	1.58e-03	7	165	2	PF00681
Domain	DUSP	USP32 USP15	1.58e-03	7	165	2	PS51283
Domain	Plectin_repeat	DST MACF1	1.58e-03	7	165	2	IPR001101
Domain	-	USP32 USP15	1.58e-03	7	165	2	3.30.2230.10
Domain	Pept_C19_DUSP	USP32 USP15	1.58e-03	7	165	2	IPR006615
Domain	PLEC	DST MACF1	1.58e-03	7	165	2	SM00250
Domain	Spectrin_repeat	KALRN DST MACF1	2.09e-03	29	165	3	IPR002017
Domain	ACTINS_1	ACTB ACTG1	2.10e-03	8	165	2	PS00406
Pathway	PID_PI3KCI_PATHWAY	YES1 PIK3R2 DAPP1 PLEKHA1 FGR FYN	4.68e-06	48	129	6	M141
Pathway	REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING	KALRN ACTB ACTG1 YES1 FYN	2.05e-05	37	129	5	MM15022
Pathway	REACTOME_RHOF_GTPASE_CYCLE	ACTB ACTG1 SENP1 PIK3R2 DIAPH3	3.42e-05	41	129	5	MM15630
Pathway	PID_AMB2_NEUTROPHILS_PATHWAY	APOB YES1 PLAUR FGR FYN	3.42e-05	41	129	5	M159
Pathway	REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING	KALRN ACTB ACTG1 YES1 FYN	3.85e-05	42	129	5	M27308
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	ANK3 DSCAM SEMA7A KALRN UNC5B NAB2 ACTB ACTG1 LAMC1 ADGRV1 ARHGAP35 YES1 PIK3R2 SCN8A RPS6KA6 FYN	7.07e-05	575	129	16	M29853
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	MYO5A ACTB ACTG1 YES1 PIK3R2 FGR FYN	8.34e-05	114	129	7	MM14814
Pathway	PID_EPHRINB_REV_PATHWAY	YES1 FGR MAPK8 FYN	1.53e-04	30	129	4	M257
Pathway	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	ANK3 ACTB ACTG1 SCN8A	1.74e-04	31	129	4	M877
Pathway	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE	INPP4A INPP4B PIK3R4	3.14e-04	15	129	3	MM14643
Pathway	REACTOME_EPH_EPHRIN_SIGNALING	KALRN ACTB ACTG1 YES1 FYN	3.16e-04	65	129	5	MM14911
Pathway	WP_FOCAL_ADHESION	ACTB ACTG1 LAMC1 PIK3R4 PIK3R2 FGR MAPK8 FYN	3.21e-04	187	129	8	MM15913
Pathway	WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY	LAMC1 YES1 DST PIK3R2 FYN	3.39e-04	66	129	5	MM15925
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	MYO5A ACTB ACTG1 YES1 PIK3R2 FGR FYN	3.40e-04	143	129	7	M27107
Pathway	REACTOME_SIGNALING_BY_VEGF	FLT4 AXL ACTB ACTG1 PIK3R2 FYN	3.62e-04	103	129	6	MM14752
Pathway	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE	INPP4A INPP4B PIK3R4	3.84e-04	16	129	3	M639
Pathway	REACTOME_SIGNALING_BY_VEGF	FLT4 AXL ACTB ACTG1 PIK3R2 FYN	4.22e-04	106	129	6	M27077
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	ATP6V1A FLT4 AXL NAB2 ACTB ACTG1 YES1 PIK3R4 PIK3R2 FGF1 TNS4 FYN	4.51e-04	418	129	12	MM15587
Pathway	WP_REGULATION_OF_ACTIN_CYTOSKELETON	ACTB ACTG1 ARHGAP35 PIK3R4 PIK3R2 FGF1 DIAPH3	4.54e-04	150	129	7	M39520
Pathway	WP_FOCAL_ADHESION	ACTB ACTG1 LAMC1 ARHGAP35 PIK3R2 FGR MAPK8 FYN	4.86e-04	199	129	8	M39402
Pathway	KEGG_FOCAL_ADHESION	FLT4 ACTB ACTG1 LAMC1 ARHGAP35 PIK3R2 MAPK8 FYN	4.86e-04	199	129	8	M7253
Pathway	WP_REGULATION_OF_ACTIN_CYTOSKELETON	ACTB ACTG1 ARHGAP35 PIK3R4 PIK3R2 FGF1 DIAPH3	4.92e-04	152	129	7	MM15834
Pathway	REACTOME_RHOF_GTPASE_CYCLE	ACTB SENP1 PIK3R2 DIAPH3	5.72e-04	42	129	4	M41821
Pathway	WP_LEPTIN_SIGNALING	ACACB LEP PIK3R2 MAPK8 FYN	6.52e-04	76	129	5	M39491
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	DSCAM SEMA7A KALRN ACTB ACTG1 ARHGAP35 YES1 PIK3R2 FYN	6.61e-04	261	129	9	MM15676
Pathway	REACTOME_PARASITE_INFECTION	MYO5A ACTB ACTG1 YES1 FGR FYN	6.82e-04	116	129	6	M29843
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	DSCAM SEMA7A MYO5A KALRN DSG3 CELA2A ACTB ACTG1 CELA2B ARHGAP35 YES1 PIK3R2 FYN	6.90e-04	502	129	13	MM14537
Pathway	REACTOME_PI_METABOLISM	INPP4A INPP4B PIK3R4 PIK3R2 PLEKHA1	6.93e-04	77	129	5	MM14590
Pathway	REACTOME_SIGNALING_BY_KIT_IN_DISEASE	YES1 PIK3R2 FYN	7.62e-04	20	129	3	M39002
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	DCHS2 FAT4 FAT3 FAT1	1.77e-08	7	167	4	16059920
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DNAJC13 ANK3 CENPC MYO5A CEP162 ACTB ACTG1 CACHD1 USP46 EHD4 SORT1 IPO9 TBC1D31 LMAN1 PRIM1 NUP210 CPSF1 PLEKHA1 CDK5RAP2 MAPK8 SLC12A7	3.73e-08	1049	167	21	27880917
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BDP1 ATP6V1A TRPM4 DNAJC13 CALD1 ANK3 MYO5A HYKK MARK3 NLGN4Y INPP4A TMEM63C WNT4 ADGRV1 ARHGAP35 SENP1 ATP2C1 ZNF827 ACKR3 KIAA1217 NUP210 VPS35L MACF1 BOD1L1 USP15	5.24e-08	1489	167	25	28611215
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ACACB ANK3 MARK3 UNC5B CACHD1 USP46 YES1 ADD1 DST PIK3R2 KIAA1217 MACF1 SLC12A7	1.45e-07	421	167	13	36976175
Pubmed	The protein tyrosine kinase family of the human genome.	FLT4 AXL YES1 AATK ROS1 FGR FYN	1.58e-07	83	167	7	11114734
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA9 PCDHA7 PCDHA4 FYN	1.65e-07	11	167	4	9655502
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	TBC1D15 DNAJC13 ANK3 CENPC MYO5A MARK3 UNC5B LAMC1 YES1 DNAJC6 ADD1 EHD4 SENP1 TBC1D31 MDN1 LMAN1 PIK3R2 NUP210 PLEKHA1 CDK5RAP2 MACF1 COL14A1 DIAPH3 EDRF1	2.05e-07	1487	167	24	33957083
Pubmed	Proteins of the CNR family are multiple receptors for Reelin.	PCDHA9 PCDHA7 PCDHA4 FYN	2.46e-07	12	167	4	10612399
Pubmed	Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice.	APOB LEP DGAT2	4.33e-07	4	167	3	18252207
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TET2 DCHS2 ANK3 OXR1 DSCAM MYO5A KALRN ACTB CACHD1 ADAMTS8 PIK3R4 ZNF34 FRY DST SLF2 VPS35L USP32 MACF1 PLAUR DGCR8 CABIN1	1.04e-06	1285	167	21	35914814
Pubmed	Palatal adhesion is dependent on Src family kinases and p38MAPK.	YES1 FGR FYN	1.08e-06	5	167	3	25354453
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	TBC1D15 CALD1 ANK3 MARK3 UNC5B CACHD1 PHGDH ADD1 DST LMAN1 PLEKHA1 MACF1 BOD1L1 DIAPH3 MED12	1.86e-06	708	167	15	39231216
Pubmed	Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.	YES1 FGR FYN	2.15e-06	6	167	3	10861086
Pubmed	Identification of hepatocarcinogen-resistance genes in DBA/2 mice.	ROS1 FGR FYN	3.75e-06	7	167	3	7705639
Pubmed	Proline-rich sequences that bind to Src homology 3 domains with individual specificities.	YES1 FGR FYN	3.75e-06	7	167	3	7536925
Pubmed	Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity.	FAT4 FAT3 FAT1	3.75e-06	7	167	3	22510986
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DNAJC13 ANK3 DSCAM MYO5A KALRN ACTB DNAJC6 CLIP1 ADD1 FRY SENP1 DST MDN1 KIAA1217 CDK5RAP2 MACF1 CABIN1	4.37e-06	963	167	17	28671696
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHA9 PCDHGA3 PCDHA7 PCDHA4	5.06e-06	24	167	4	24698270
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATP6V1A DENND2A DNAJC13 CALD1 ANK3 OXR1 MYO5A KALRN MARK3 INPP4A ACTB ACTG1 ARHGAP35 DNAJC6 PHGDH ADD1 PIK3R4 DST KIAA1217 MACF1 KNG1	5.59e-06	1431	167	21	37142655
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ATP6V1A FAT4 DNAJC13 ACACB ANK3 DSCAM CEP162 APOB PKHD1L1 ADD1 FAT1 DST CDK5RAP2 DGCR8 PCDH9	5.73e-06	777	167	15	35844135
Pubmed	Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.	YES1 FGR FYN	5.98e-06	8	167	3	15190072
Pubmed	Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis.	YES1 FGR FYN	5.98e-06	8	167	3	16921024
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	DNAJC13 DSCAM ACTB ACTG1 LAMC1 POTEKP NUP210 CPSF1	6.48e-06	202	167	8	24639526
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	TBC1D15 CALD1 CENPC ERAP1 LAMC1 ARHGAP35 THAP11 FAT1 IPO9 MDN1 VILL CDK5RAP2 USP15 LRIF1	6.69e-06	689	167	14	36543142
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA9 PCDHGA3 PCDHA7 PCDHA4	9.60e-06	28	167	4	15347688
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	BDP1 DENND2A NLGN4X KIAA1217 MACF1 GRIP2	1.09e-05	103	167	6	10574462
Pubmed	Expression of tyrosine kinase gene in mouse thymic stromal cells.	AXL FGR FYN	1.27e-05	10	167	3	8943574
Pubmed	The docking protein Cas links tyrosine phosphorylation signaling to elongation of cerebellar granule cell axons.	YES1 MAPK8 FYN	1.27e-05	10	167	3	16687575
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ERAP1 ADGRV1 ARHGAP35 AATK DST MACF1 GRIP2 USP15	1.42e-05	225	167	8	12168954
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	TRPM4 OXR1 UNC5B ACTG1 YES1 ADD1 EHD4 TRAP1 FAT1 SENP1 ATP2C1 LMAN1 USP32 PLEKHA1 SLC12A7 PCDH9	1.55e-05	952	167	16	38569033
Pubmed	HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells.	ACTB ACTG1 MAPK8	1.74e-05	11	167	3	14597672
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 MARK3 CEP162 LAMC1 PIK3R4 IPO9 DST MDN1 SLF2 IKBKE KIAA1217 PLEKHA1 MACF1 BOD1L1 EDRF1	1.91e-05	861	167	15	36931259
Pubmed	Proteomic analysis reveals novel binding partners of MIP-T3 in human cells.	ACTB ACTG1 PHGDH TRAP1	2.13e-05	34	167	4	20391533
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TRPM4 MARK3 UNC5B APOB YES1 FAT1 NLGN4X USP32 PLEKHA1 DIAPH3 ABCC2 SLC12A7	2.16e-05	569	167	12	30639242
Pubmed	Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes.	ACTB ACTG1	2.29e-05	2	167	2	21778137
Pubmed	Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.	FLT4 PDPN	2.29e-05	2	167	2	18212541
Pubmed	De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome.	ACTB ACTG1	2.29e-05	2	167	2	22366783
Pubmed	Sortilin/Omentin-1 ratio in peripheral artery disease: A cross-sectional study on 295 unselected elderly patients.	ITLN1 SORT1	2.29e-05	2	167	2	35500800
Pubmed	Acf7 (MACF) is an actin and microtubule linker protein whose expression predominates in neural, muscle, and lung development.	DST MACF1	2.29e-05	2	167	2	11002341
Pubmed	Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism.	APOB SORT1	2.29e-05	2	167	2	22751103
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4Y NLGN4X	2.29e-05	2	167	2	23183221
Pubmed	Isolation of cDNA clones for mouse cytoskeletal gamma-actin and differential expression of cytoskeletal actin mRNAs in mouse cells.	ACTB ACTG1	2.29e-05	2	167	2	3221869
Pubmed	Differential effects of the Src family tyrosine kinases Yes and Fyn on lipopolysaccharide-induced lung injury in mice.	YES1 FYN	2.29e-05	2	167	2	34105991
Pubmed	Measurements of spatiotemporal changes in G-actin concentration reveal its effect on stimulus-induced actin assembly and lamellipodium extension.	ACTB ACTG1	2.29e-05	2	167	2	21502360
Pubmed	The evolution and complexity of the genes encoding the cytoskeletal proteins of human epidermal cells.	ACTB ACTG1	2.29e-05	2	167	2	6686106
Pubmed	Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity.	ACTB ACTG1	2.29e-05	2	167	2	19638415
Pubmed	Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177.	ACTB ACTG1	2.29e-05	2	167	2	3335520
Pubmed	High level expression of transfected beta- and gamma-actin genes differentially impacts on myoblast cytoarchitecture.	ACTB ACTG1	2.29e-05	2	167	2	1577857
Pubmed	Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions.	ITLN1 LEP	2.29e-05	2	167	2	23144698
Pubmed	Elastase-2, a Tissue Alternative Pathway for Angiotensin II Generation, Plays a Role in Circulatory Sympathovagal Balance in Mice.	CELA2A CELA2B	2.29e-05	2	167	2	28386233
Pubmed	A negative feedback loop between TET2 and leptin in adipocyte regulates body weight.	TET2 LEP	2.29e-05	2	167	2	38561362
Pubmed	The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.	YES1 FYN	2.29e-05	2	167	2	1384720
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4Y NLGN4X	2.29e-05	2	167	2	18434543
Pubmed	Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations.	ACTB ACTG1	2.29e-05	2	167	2	23756437
Pubmed	Cytochalasin D-induced actin gene expression in murine erythroleukemia cells.	ACTB ACTG1	2.29e-05	2	167	2	8482333
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4Y NLGN4X	2.29e-05	2	167	2	37080762
Pubmed	Impaired muscle relaxation and mitochondrial fission associated with genetic ablation of cytoplasmic actin isoforms.	ACTB ACTG1	2.29e-05	2	167	2	29265728
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4Y NLGN4X	2.29e-05	2	167	2	29106499
Pubmed	Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia.	ACTB ACTG1	2.29e-05	2	167	2	22246323
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4Y NLGN4X	2.29e-05	2	167	2	26456829
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4Y NLGN4X	2.29e-05	2	167	2	24104404
Pubmed	Characterization of pancreatic elastase II cDNAs: two elastase II mRNAs are expressed in human pancreas.	CELA2A CELA2B	2.29e-05	2	167	2	3646943
Pubmed	Prevalence of Cytoplasmic Actin Mutations in Diffuse Large B-Cell Lymphoma and Multiple Myeloma: A Functional Assessment Based on Actin Three-Dimensional Structures.	ACTB ACTG1	2.29e-05	2	167	2	32349449
Pubmed	Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings.	ACTB ACTG1	2.29e-05	2	167	2	32506774
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4Y NLGN4X	2.29e-05	2	167	2	22989184
Pubmed	Inhibition of insulin/PI3K/AKT signaling decreases adipose Sortilin 1 in mice and 3T3-L1 adipocytes.	LEP SORT1	2.29e-05	2	167	2	28844948
Pubmed	Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation.	ACTB ACTG1	2.29e-05	2	167	2	20847274
Pubmed	Preferential targeting of Nav1.6 voltage-gated Na+ Channels to the axon initial segment during development.	ANK3 SCN8A	2.29e-05	2	167	2	25874799
Pubmed	Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.	LEP MAPK8	2.29e-05	2	167	2	17416798
Pubmed	Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing.	ACTB ACTG1	2.29e-05	2	167	2	32588558
Pubmed	Baraitser-Winter cerebrofrontofacial syndrome.	ACTB ACTG1	2.29e-05	2	167	2	27625340
Pubmed	Stress-induced phosphorylation of CLIP-170 by JNK promotes microtubule rescue.	CLIP1 MAPK8	2.29e-05	2	167	2	32491151
Pubmed	High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.	PLAUR KNG1	2.29e-05	2	167	2	24688027
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4Y NLGN4X	2.29e-05	2	167	2	24855039
Pubmed	The isolation and characterization of cDNA encoding human and rat brain inositol polyphosphate 4-phosphatase.	INPP4A INPP4B	2.29e-05	2	167	2	7608176
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4Y NLGN4X	2.29e-05	2	167	2	37001827
Pubmed	The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family.	INPP4A INPP4B	2.29e-05	2	167	2	9295334
Pubmed	Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells.	PLAUR KNG1	2.29e-05	2	167	2	15044324
Pubmed	Actin amino-acid sequences. Comparison of actins from calf thymus, bovine brain, and SV40-transformed mouse 3T3 cells with rabbit skeletal muscle actin.	ACTB ACTG1	2.29e-05	2	167	2	213279
Pubmed	The First Korean Case of Baraitser-Winter Cerebro-Fronto-Facial Syndrome with a Novel Mutation in ACTB Diagnosed Via Targeted Gene Panel Sequencing and Literature Review.	ACTB ACTG1	2.29e-05	2	167	2	33334799
Pubmed	β-Actin specifically controls cell growth, migration, and the G-actin pool.	ACTB ACTG1	2.29e-05	2	167	2	21900491
Pubmed	Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice.	LEP SORT1	2.29e-05	2	167	2	23904453
Pubmed	Correlations of Omentin-1 and Leptin with Bone Metabolism and Plasma Glucose Upon Type 2 Diabetes Mellitus and Osteoporosis.	ITLN1 LEP	2.29e-05	2	167	2	36912310
Pubmed	Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor.	PLAUR KNG1	2.29e-05	2	167	2	14764580
Pubmed	Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation.	PLAUR KNG1	2.29e-05	2	167	2	12023845
Pubmed	Ankyrin-G regulates inactivation gating of the neuronal sodium channel, Nav1.6.	ANK3 SCN8A	2.29e-05	2	167	2	16775201
Pubmed	Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization.	ACTB ACTG1	2.29e-05	2	167	2	9288906
Pubmed	Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates.	LEP MAPK8	2.29e-05	2	167	2	17050683
Pubmed	Contribution of ApoB-100/SORT1-Mediated Immune Microenvironment in Regulating Oxidative Stress, Inflammation, and Ferroptosis After Spinal Cord Injury.	APOB SORT1	2.29e-05	2	167	2	38337131
Pubmed	Baraitser-Winter Cerebrofrontofacial Syndrome	ACTB ACTG1	2.29e-05	2	167	2	26583190
Pubmed	Knockout of ACTB and ACTG1 with CRISPR/Cas9(D10A) Technique Shows that Non-Muscle β and γ Actin Are Not Equal in Relation to Human Melanoma Cells' Motility and Focal Adhesion Formation.	ACTB ACTG1	2.29e-05	2	167	2	32326615
Pubmed	Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans.	CELA2A CELA2B	2.29e-05	2	167	2	16327289
Pubmed	Gene and protein expression in the epididymis of infertile c-ros receptor tyrosine kinase-deficient mice.	SLC1A7 ROS1	2.29e-05	2	167	2	12890734
Pubmed	Identification of new human cadherin genes using a combination of protein motif search and gene finding methods.	DCHS2 FAT4	2.29e-05	2	167	2	15003449
Pubmed	Autocrine FGF1 signaling promotes glucose uptake in adipocytes.	LEP FGF1	2.29e-05	2	167	2	36161959
Pubmed	Isoform-specific mutation in Dystonin-b gene causes late-onset protein aggregate myopathy and cardiomyopathy.	ACTB DST	2.29e-05	2	167	2	35942699
Pubmed	p85β regulates autophagic degradation of AXL to activate oncogenic signaling.	AXL PIK3R2	2.29e-05	2	167	2	32385243
Pubmed	Structure, chromosome location, and expression of the human gamma-actin gene: differential evolution, location, and expression of the cytoskeletal beta- and gamma-actin genes.	ACTB ACTG1	2.29e-05	2	167	2	2837653
Pubmed	A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.	NLGN4Y NLGN4X	2.29e-05	2	167	2	32243781
Pubmed	Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase.	LEP MAPK8	2.29e-05	2	167	2	12902351
Interaction	RHOF interactions	TRPM4 FAT4 ANK3 ATR MYO5A MARK3 UNC5B ACTB YES1 BTN3A2 ADD1 EHD4 FAT1 SENP1 MDN1 LMAN1 PIK3R2 PLEKHA1 MACF1 DIAPH3 SLC12A7 FYN	3.74e-08	673	166	22	int:RHOF
Interaction	RHOJ interactions	MARK3 UNC5B CACHD1 ARHGAP35 YES1 ADD1 EHD4 TRAP1 FAT1 SENP1 ATP2C1 MDN1 LMAN1 PIK3R2 PLEKHA1 MACF1 DIAPH3 SLC12A7 IL4R	1.23e-06	633	166	19	int:RHOJ
Interaction	C2CD4B interactions	FAT4 FAT3 ADGRV1 FAT1 FEZ2 MACF1	1.55e-06	44	166	6	int:C2CD4B
Interaction	LAMTOR1 interactions	ATP6V1A DNAJC13 OXR1 MYO5A MARK3 UNC5B CACHD1 YES1 ADD1 EHD4 PIK3R4 ATP2C1 DST SNX7 PIK3R2 USP32 PLEKHA1 DIAPH3 SLC12A7 EDRF1	2.17e-06	722	166	20	int:LAMTOR1
Interaction	RND3 interactions	ANK3 MYO5A MARK3 UNC5B ARHGAP35 YES1 ADD1 DST PIK3R2 KIAA1217 PLEKHA1 SLC12A7	2.87e-06	273	166	12	int:RND3
Interaction	TMEM204 interactions	FLT4 AXL SLC12A7 FYN	3.00e-06	13	166	4	int:TMEM204
Interaction	MAPRE3 interactions	CENPC MARK3 CEP162 TACC2 CLIP1 PIK3R4 DST KIAA1217 CDK5RAP2 MACF1 DIAPH3	3.37e-06	230	166	11	int:MAPRE3
Interaction	UBXN6 interactions	CTC1 AXL NAB2 DST MDN1 LMAN1 PIK3R2 PRIM1 USP32 TNS4 MAPK8 EDRF1	1.68e-05	325	166	12	int:UBXN6
Interaction	XAGE1A interactions	FAT4 FAT3 ADGRV1 FAT1 CABIN1	2.10e-05	41	166	5	int:XAGE1A
Interaction	EPB41L4A interactions	ANK3 MARK3 ADD1 DST MDN1 KIAA1217 PLEKHA1 MACF1	2.13e-05	140	166	8	int:EPB41L4A
Interaction	RAB35 interactions	ANK3 MYO5A MARK3 UNC5B CACHD1 YES1 BTN3A2 ADD1 DST LMAN1 PIK3R2 USP32 PLEKHA1 MACF1 DIAPH3 SLC12A7	2.18e-05	573	166	16	int:RAB35
Interaction	RHOU interactions	RAD51D ATP6V1A ANK3 MYO5A MARK3 UNC5B YES1 ADD1 EHD4 DST PIK3R2 PLEKHA1 MACF1 SLC12A7 FYN	2.19e-05	510	166	15	int:RHOU
Interaction	MAPRE1 interactions	CEP162 TACC2 YES1 DNAJC6 CLIP1 ADD1 PIK3R4 DST TBC1D31 KIAA1217 NUP210 CDK5RAP2 MACF1 DIAPH3 FYN	2.40e-05	514	166	15	int:MAPRE1
Interaction	LOC254896 interactions	RAD51D FAT4 FAT3 ADGRV1 FAT1	2.67e-05	43	166	5	int:LOC254896
Interaction	GJA1 interactions	ANK3 KALRN MARK3 UNC5B APOB CACHD1 YES1 PIK3R4 DST LMAN1 PIK3R2 KIAA1217 PLEKHA1 MACF1 SLC12A7 PCDH9	2.69e-05	583	166	16	int:GJA1
Interaction	LYN interactions	ANK3 MARK3 UNC5B ACTB CACHD1 YES1 ADD1 DST LMAN1 CLYBL PIK3R2 KIAA1217 DAPP1 PLEKHA1 MACF1 PLAUR FGR SLC12A7	2.86e-05	720	166	18	int:LYN
Interaction	SLC31A1 interactions	AXL PHGDH INPP4B THAP11 ATP2C1 PIK3R2 PRIM1 USP32 SLC12A7	3.14e-05	192	166	9	int:SLC31A1
Interaction	UCN3 interactions	FAT4 FAT3 ADGRV1 FAT1	3.48e-05	23	166	4	int:UCN3
Interaction	FLOT1 interactions	CALD1 ANK3 MARK3 UNC5B YES1 ADD1 DST PIK3R2 KIAA1217 PLEKHA1 MACF1 BOD1L1 SLC12A7 FYN	4.06e-05	475	166	14	int:FLOT1
Interaction	SHC1 interactions	FLT4 CALD1 AXL MAT1A ACTB ACTG1 YES1 PIK3R2 MAPK8 USP15 FYN IL4R	4.81e-05	362	166	12	int:SHC1
Interaction	RHOA interactions	FAT4 ANK3 ERAP1 MARK3 UNC5B ARHGAP35 YES1 CLIP1 BTN3A2 TRAP1 FAT1 SENP1 ATP2C1 IPO9 MDN1 LMAN1 PIK3R2 NUP210 PLEKHA1 MACF1 DIAPH3 MAPK8 SLC12A7 FYN	4.85e-05	1199	166	24	int:RHOA
Interaction	C11orf52 interactions	ANK3 MARK3 UNC5B CACHD1 YES1 ADD1 DST PIK3R2 PLEKHA1 MACF1 SLC12A7	5.60e-05	311	166	11	int:C11orf52
Interaction	IFNE interactions	FAT4 ACACB ADGRV1 FAT1	6.72e-05	27	166	4	int:IFNE
Interaction	TPTE2 interactions	TBC1D15 CALD1 AATK TBC1D31 CDK5RAP2 DIAPH3	6.82e-05	84	166	6	int:TPTE2
Interaction	OCLN interactions	DNAJC13 ANK3 MARK3 AXL UNC5B CACHD1 YES1 ADD1 DST LMAN1 PIK3R2 PLEKHA1 MACF1 SLC12A7	7.04e-05	500	166	14	int:OCLN
Interaction	RHOQ interactions	MYO5A MARK3 AXL UNC5B CACHD1 YES1 ADD1 FAT1 DST PIK3R2 PLEKHA1 DIAPH3 SLC12A7	7.87e-05	442	166	13	int:RHOQ
Interaction	RHOD interactions	ANK3 MYO5A MARK3 ARHGAP35 YES1 ADD1 EHD4 SENP1 MDN1 LMAN1 PIK3R2 PLEKHA1 MACF1 DIAPH3 SLC12A7	8.07e-05	572	166	15	int:RHOD
Interaction	CDC42 interactions	ATP6V1A FAT4 ANK3 ATR MARK3 UNC5B ACTB ARHGAP35 YES1 CLIP1 BTN3A2 EHD4 FAT1 SENP1 IPO9 MDN1 LMAN1 PIK3R2 NUP210 PLEKHA1 DIAPH3 MAPK8 SLC12A7 FYN LRIF1	8.42e-05	1323	166	25	int:CDC42
Interaction	RHOH interactions	MYO5A MARK3 UNC5B YES1 ADD1 EHD4 DST MDN1 LMAN1 PIK3R2 PLEKHA1 SLC12A7 FYN LRIF1	9.06e-05	512	166	14	int:RHOH
Interaction	ARF6 interactions	TRPM4 FLT4 ANK3 MARK3 AXL UNC5B CACHD1 YES1 ADD1 IPO9 LMAN1 PIK3R2 PLEKHA1 CDK5RAP2 SLC12A7	1.02e-04	584	166	15	int:ARF6
Interaction	PPIAL4G interactions	FAT4 FAT3 ACTB YES1	1.03e-04	30	166	4	int:PPIAL4G
Interaction	LCK interactions	ANK3 MYO5A KALRN MARK3 AXL YES1 DST PIK3R2 KIAA1217 DAPP1 MACF1 FYN EDRF1	1.25e-04	463	166	13	int:LCK
Interaction	RET interactions	FLT4 ANK3 AXL UNC5B TACC2 SORT1 FAT1 LMAN1 PIK3R2 MAPK8	1.27e-04	284	166	10	int:RET
Interaction	PCDHA4 interactions	PCDHA9 PCDHA7 PCDHA4 LRIF1 ANAPC4	1.35e-04	60	166	5	int:PCDHA4
Interaction	KALRN interactions	DSCAM MYO5A KALRN LHCGR MACF1 FYN	1.43e-04	96	166	6	int:KALRN
Interaction	TRAF3IP1 interactions	ACTB ACTG1 PHGDH TRAP1 DST MACF1	1.43e-04	96	166	6	int:TRAF3IP1
Interaction	NXPH2 interactions	FAT4 ADGRV1 FAT1 PCDH9	1.51e-04	33	166	4	int:NXPH2
Interaction	RAB11A interactions	DNAJC13 CALD1 ACACB ATR OXR1 MYO5A MARK3 ACTB MUC19 CACHD1 YES1 EHD4 DST LMAN1 USP32 PLEKHA1 DIAPH3 SLC12A7	1.74e-04	830	166	18	int:RAB11A
Interaction	KCNE3 interactions	AXL YES1 THAP11 DST PIK3R2 USP32 ABCC2 SLC12A7 PCDH9 LRIF1	1.78e-04	296	166	10	int:KCNE3
Interaction	RAC1 interactions	ANK3 KALRN MARK3 UNC5B ACTB ARHGAP35 YES1 CLIP1 ADD1 EHD4 FAT1 SENP1 DST MDN1 LMAN1 PIK3R2 PLEKHA1 MACF1 DIAPH3 SLC12A7 FYN	1.80e-04	1063	166	21	int:RAC1
Interaction	ERBB3 interactions	FLT4 AXL ACTB ACTG1 POTEKP YES1 PIK3R2 NUP210 DAPP1 TNS4 FGR	1.80e-04	355	166	11	int:ERBB3
Interaction	DCTN4 interactions	CALD1 ACTB ACTG1 CLIP1 WDFY4 AATK USP15	1.85e-04	143	166	7	int:DCTN4
Interaction	PCDHA7 interactions	PCDHA9 PCDHA7 PCDHA4	1.87e-04	14	166	3	int:PCDHA7
Interaction	MCPH1 interactions	ATR ACTG1 THAP11 TRAP1 ZNF827 ABCC2	1.90e-04	101	166	6	int:MCPH1
Interaction	RAC3 interactions	FAT4 MARK3 UNC5B ARHGAP35 YES1 ADD1 FAT1 SENP1 LMAN1 PIK3R2 KIAA1217 PLEKHA1 MACF1 DIAPH3 SLC12A7	1.92e-04	619	166	15	int:RAC3
Interaction	RHOB interactions	FAT4 ANK3 MARK3 UNC5B CACHD1 ARHGAP35 YES1 PHGDH FAT1 MDN1 LMAN1 PIK3R2 USP32 PLEKHA1 MACF1 DIAPH3 SLC12A7 FYN	2.02e-04	840	166	18	int:RHOB
Interaction	RND1 interactions	MARK3 UNC5B ARHGAP35 YES1 EHD4 DST LMAN1 PIK3R2 SLC12A7	2.09e-04	246	166	9	int:RND1
Interaction	PPP1R9B interactions	ATP6V1A CALD1 ANK3 MYO5A ACTB ACTG1 LAMC1 USP46 DNAJC6 PHGDH ADD1 PPP1R3A AATK KIAA1217 BOD1L1	2.16e-04	626	166	15	int:PPP1R9B
Interaction	NRAS interactions	TRPM4 MARK3 UNC5B FBP2 CACHD1 YES1 ADD1 FAT1 NLGN4X LMAN1 USP32 PLEKHA1 MACF1 SLC12A7 PCDH9 LRIF1	2.23e-04	699	166	16	int:NRAS
Interaction	ACTB interactions	TET2 GPR3 ATP6V1A CALD1 ACTB ACTG1 POTEKP USP46 ARHGAP35 WDFY4 PHGDH ZUP1 ADD1 TRAP1 IPO9 DST PIK3R2 MACF1 DIAPH3 FGR USP15	2.32e-04	1083	166	21	int:ACTB
Interaction	PRSS37 interactions	FAT4 ADGRV1 FAT1	2.32e-04	15	166	3	int:PRSS37
Interaction	RND2 interactions	MARK3 UNC5B ARHGAP35 YES1 SENP1 DST MDN1 LMAN1 PIK3R2 PLEKHA1 SLC12A7 FYN	2.98e-04	440	166	12	int:RND2
Interaction	CX3CL1 interactions	FAT4 FLT4 FAT3 PIK3R2 USP32	3.00e-04	71	166	5	int:CX3CL1
Interaction	EPHA2 interactions	FLT4 ACACB ANK3 MARK3 AXL UNC5B CACHD1 USP46 YES1 ADD1 DST LMAN1 PIK3R2 KIAA1217 MACF1 SLC12A7	3.05e-04	719	166	16	int:EPHA2
Interaction	DNAJC5 interactions	ANK3 MYO5A MARK3 UNC5B YES1 ADD1 LMAN1 PIK3R2 PLEKHA1 MACF1 EDRF1	3.08e-04	378	166	11	int:DNAJC5
Interaction	KCNA3 interactions	TBC1D15 CALD1 ANK3 MARK3 UNC5B CACHD1 CLIP1 PHGDH ADD1 DST LMAN1 PLEKHA1 CDK5RAP2 MACF1 BOD1L1 DIAPH3 FYN MED12	3.13e-04	871	166	18	int:KCNA3
Interaction	DKKL1 interactions	RAD51D FAT4 FAT3 ADGRV1 FAT1 MDN1	3.17e-04	111	166	6	int:DKKL1
Interaction	DIRAS3 interactions	ANK3 MARK3 CACHD1 YES1 DST FEZ2 PLEKHA1 MACF1 SLC12A7	3.32e-04	262	166	9	int:DIRAS3
Interaction	OPALIN interactions	ATR ERAP1 AXL USP46 YES1 ATP2C1 MDN1 ABCC2	3.48e-04	209	166	8	int:OPALIN
Interaction	MLF1 interactions	DNAJC13 ACACB APOB CDK5RAP2 EDRF1 KNG1	3.48e-04	113	166	6	int:MLF1
Interaction	PSG8 interactions	FAT4 TBC1D15 ADGRV1 FAT1	3.55e-04	41	166	4	int:PSG8
Interaction	STYK1 interactions	MARK3 UNC5B PIK3R4 SENP1 DST PIK3R2 PLEKHA1	3.82e-04	161	166	7	int:STYK1
Interaction	DOK2 interactions	ACTB ACTG1 YES1 USP15 FYN IL4R	4.01e-04	116	166	6	int:DOK2
Interaction	VPS26C interactions	TET2 MAT1A ZUP1 VPS35L LRIF1	4.11e-04	76	166	5	int:VPS26C
Interaction	EPHB2 interactions	ANK3 KALRN MARK3 UNC5B YES1 MDN1 PIK3R2 PLEKHA1	4.33e-04	216	166	8	int:EPHB2
Cytoband	8q23	OXR1 PKHD1L1 COL14A1	3.71e-05	18	167	3	8q23
Cytoband	5q31	PCDHA9 PCDHGA3 PCDHA7 PCDHA4 FGF1	6.67e-05	115	167	5	5q31
Cytoband	3q22.1	DNAJC13 PIK3R4 ATP2C1	4.89e-04	42	167	3	3q22.1
GeneFamily	Cadherin related	DCHS2 FAT4 FAT3 FAT1	3.23e-06	17	113	4	24
GeneFamily	SH2 domain containing	YES1 PIK3R2 DAPP1 TNS4 FGR FYN	4.08e-05	101	113	6	741
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	FLT4 AXL AATK ROS1	1.11e-04	40	113	4	321
GeneFamily	Actins	ACTB ACTG1	5.71e-04	6	113	2	929
GeneFamily	Clustered protocadherins	PCDHA9 PCDHGA3 PCDHA7 PCDHA4	6.89e-04	64	113	4	20
GeneFamily	EF-hand domain containing\|Plakins	DST MACF1	1.06e-03	8	113	2	939
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	INPP4A CAPN6 INPP4B	1.46e-03	36	113	3	823
GeneFamily	Fibronectin type III domain containing	DSCAM KALRN AXL COL14A1 ROS1	3.32e-03	160	113	5	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FLT4 DSCAM KALRN UNC5B ADGRF5	3.41e-03	161	113	5	593
GeneFamily	Ubiquitin specific peptidases	USP46 USP32 USP15	5.18e-03	56	113	3	366
Coexpression	HAY_BONE_MARROW_STROMAL	DENND2A CALD1 NLGN4Y UNC5B FAT3 RGS22 LAMC1 APOB TACC2 CACHD1 WNT4 FAT1 NLGN4X KCNT2 COL21A1 SNX7 ACKR3 KIAA1217 FGF1 COL14A1	9.50e-08	767	166	20	M39209
Coexpression	FIRESTEIN_PROLIFERATION	ATR KALRN AXL INPP4A IKBKE RPS6KA6 ROS1 MAPK8 FYN	1.19e-06	166	166	9	M5354
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	BDP1 ANK3 DSCAM MYO5A RAPGEF5 INPP4A MUC19 PCDHA7 ARHGAP35 DNAJC6 CLIP1 EHD4 FRY MICU3 AATK MDN1 NLGN4X SCN8A PLEKHA1 BOD1L1 GRIP2 PCDH9	2.05e-06	1106	166	22	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DNAJC13 ATR CENPC MARK3 LAMC1 ARHGAP35 CLIP1 PIK3R4 FAT1 ATP2C1 DST TBC1D31 MDN1 MACF1 PLAUR MAPK8 USP15 FYN	8.87e-06	856	166	18	M4500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	ANK3 DSCAM KALRN RAPGEF5 MUC19 DNAJC6 FRY MICU3 AATK SCN8A GRIP2 MAPK8 PCDH9	8.99e-06	465	166	13	M39066
Coexpression	BROWNE_HCMV_INFECTION_14HR_DN	NLGN4Y AXL BTN3A2 INPP4B ADD1 PDPN DST ACKR3 CPSF1 PLAUR	1.72e-05	290	166	10	M13251
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL	C6orf62 ANK3 ERAP1 AXL ITLN1 CEP162 UNC5B CACHD1 ADAMTS8 PKHD1L1 EHD4 PDPN FRY ATP2C1 KCNT2 ACKR3 PLEKHA1 PLAUR	3.78e-05	955	166	18	M45680
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HOMTN	ATP6V1A ANK3 MYO5A RAPGEF5 PCDHA7 DNAJC6 FRY AATK SCN8A FGF1 PCDH9	4.04e-05	389	166	11	M39073
Coexpression	GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN	MYO5A ERAP1 LAMC1 TACC2 DNAJC6 IKBKE SNX7 SLC12A7	4.30e-05	200	166	8	M6449
Coexpression	GOZGIT_ESR1_TARGETS_UP	ACACB LAMC1 WNT4 FRY DST COL21A1 FYN	4.75e-05	149	166	7	M13944
Coexpression	LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX	BDP1 ATP6V1A OXR1 CLIP1 KIAA1217 ADGRF5 MAPK8	5.39e-05	152	166	7	M39239
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	TET2 CALD1 FRY FAT1 DST FGF1 MACF1 FYN	6.48e-05	212	166	8	M39221
Coexpression	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	ANK3 FBP2 AATK MDN1 IL4R	7.24e-05	68	166	5	MM803
Coexpression	LIU_PROSTATE_CANCER_DN	CALD1 ACACB UNC5B CACHD1 DST ZNF827 SNX7 ACKR3 COL14A1 TNS4 FYN PCDH9	7.64e-05	493	166	12	M19391
Coexpression	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	ANK3 FBP2 AATK MDN1 IL4R	7.77e-05	69	166	5	M19523
Coexpression	GSE13547_WT_VS_ZFX_KO_BCELL_UP	OXR1 INPP4B FRY DST ACCS PLEKHA1 FYN	8.38e-05	163	166	7	M2997
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	TET2 ACACB FRY NUP210 MACF1 BOD1L1 CABIN1	9.39e-05	166	166	7	M6826
Coexpression	RIGGI_EWING_SARCOMA_PROGENITOR_UP	TRPM4 FAT4 TSPAN11 ACACB KALRN FAT3 CACHD1 NLGN4X COL21A1 KIAA1217 PCDH9	1.14e-04	437	166	11	M15981
Coexpression	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	SEMA7A MARK3 APOB ADD1 ADGRF5	1.31e-04	77	166	5	M1992
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	CALD1 KALRN RAPGEF5 INPP4B DST ADGRF5 PCDH9	1.40e-04	177	166	7	M39245
CoexpressionAtlas	seminal vesicle	VIPR2 CALD1 NLGN4Y UNC5B FAT3 CAPN6 HS3ST5 GPR149	8.91e-06	134	162	8	seminal vesicle
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 KALRN FAT3 RGS22 APOB ADGRV1 PKD1L2 PKHD1L1 FAT1 ROS1	2.08e-09	184	167	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 KALRN FAT3 RGS22 APOB ADGRV1 PKD1L2 PKHD1L1 FAT1 ROS1	2.08e-09	184	167	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 KALRN FAT3 RGS22 APOB ADGRV1 PKD1L2 PKHD1L1 FAT1 ROS1	2.08e-09	184	167	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CALD1 KALRN FAT3 INPP4B SORT1 FRY KCNT2 RPS6KA6 MACF1 COL14A1	2.69e-09	189	167	10	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	Endothelial-B-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	DENND2A FLT4 TSPAN11 CALD1 KALRN PKHD1L1 PDPN ACKR3 VPS35L	1.88e-08	172	167	9	8a527dff06d841a86c7eb04a1dd9630787294da4
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DENND2A FLT4 CALD1 KALRN RAPGEF5 PKHD1L1 PDPN DST MACF1	2.54e-08	178	167	9	ad3de3e03a401dac64431a541899445262246347
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	CALD1 ACACB ANK3 TACC2 INPP4B FRY DST COL21A1 PCDH9	3.38e-08	184	167	9	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	KALRN RAPGEF5 FAT3 INPP4B SORT1 FRY COL21A1 MACF1 COL14A1	4.06e-08	188	167	9	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	Control-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	CALD1 KALRN RAPGEF5 ACTB INPP4B SORT1 FRY FGF1 ADGRF5	4.65e-08	191	167	9	2da83c493e60ad0278848957645277d76737a188
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A FAT4 CALD1 FAT3 LAMC1 ADAMTS8 DST COL21A1 MACF1	4.65e-08	191	167	9	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A CALD1 FAT3 LAMC1 ADAMTS8 INPP4B DST COL21A1 MACF1	4.87e-08	192	167	9	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP6V1A OXR1 RAPGEF5 CLIP1 ADD1 EHD4 FGF1 MACF1 BOD1L1	4.87e-08	192	167	9	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VIPR2 CALD1 KALRN RAPGEF5 AXL INPP4B FRY KCNT2 COL21A1	5.81e-08	196	167	9	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	Tracheal-10x3prime_v2-Stromal-Mesofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CALD1 AXL FAT3 ADAMTS8 PIK3R4 USP32 ACCS COL14A1 GRIP2	6.07e-08	197	167	9	d7cef7881abd807a679432766ced609a6efd1067
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	CALD1 INPP4B SORT1 FRY TBC1D31 KIAA1217 FGF1 ADGRF5 GRIP2	6.07e-08	197	167	9	98f0184a09563a544f0c2d4df22c9db2fbc95019
ToppCell	Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CALD1 AXL FAT3 ADAMTS8 PIK3R4 USP32 ACCS COL14A1 GRIP2	6.07e-08	197	167	9	20a5958512bdb99daeb8f4d244df53e4f048f879
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DENND2A FAT4 CALD1 KALRN FAT3 DST KCNT2 COL21A1 COL14A1	6.34e-08	198	167	9	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Fetal_29-31_weeks\|World / Lineage, Cell type, age group and donor	DENND2A FAT4 CALD1 KALRN FAT3 ACTG1 KCNT2 COL21A1 COL14A1	6.62e-08	199	167	9	5b9d355795dd03a22f0961dfd143425c367a4654
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	FLT4 ITLN1 UNC13D DST ZNF827 KIAA1217 PLEKHA1 MACF1 ADGRF5	6.62e-08	199	167	9	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VIPR2 DENND2A CALD1 KALRN AXL ADAMTS8 CELA2B INPP4B WDR87	6.62e-08	199	167	9	b768496381362f9a2706e0892b5a7a0db82e09ce
ToppCell	(02)_MMP9/10+\|World / shred by cell type by condition	CALD1 SEMA7A AXL ACTB PDPN DST FGF1 PLAUR TNS4	6.62e-08	199	167	9	3f78eddeaa67d3b767aa38de765632166b09a4f0
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	FAT4 RAPGEF5 EHD4 DST KIAA1217 PLEKHA1 MACF1 ADGRF5 FYN	6.91e-08	200	167	9	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VIPR2 DENND2A FAT4 CALD1 LAMC1 KCNT2 ACKR3 COL14A1 FYN	6.91e-08	200	167	9	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	COVID-19-kidney-Lymphatic_EC\|kidney / Disease (COVID-19 only), tissue and cell type	FLT4 TSPAN11 CALD1 KALRN UNC5B PKHD1L1 PDPN ACKR3	2.34e-07	167	167	8	97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TSPAN11 ANK3 DNAJC6 DST NLGN4X COL21A1 KIAA1217 PCDH9	2.44e-07	168	167	8	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 MYO5A FAT3 CELA2A ACTB DST ZNF827 MACF1	3.06e-07	173	167	8	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 MYO5A FAT3 CELA2A ACTB DST ZNF827 MACF1	3.06e-07	173	167	8	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 MYO5A FAT3 CELA2A ACTB DST ZNF827 MACF1	3.06e-07	173	167	8	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIPR2 ACACB FAT3 CELA2A CACHD1 PKD1L2 PHGDH FYN	3.20e-07	174	167	8	4289dfc7613db4bb3d706b9b65d06e84c0c53558
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIPR2 ACACB FAT3 CELA2A CACHD1 PKD1L2 PHGDH FYN	3.20e-07	174	167	8	165e14cad57e90aa247dcecfaa3c2e8ff2a470ad
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	CALD1 DSG3 FAT3 LAMC1 FAT1 IPO9 COL21A1 ACKR3	3.20e-07	174	167	8	fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 MYO5A FAT3 CELA2A ACTB DST ZNF827 MACF1	3.34e-07	175	167	8	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	IPF-Epithelial-Mesothelial\|IPF / Disease state, Lineage and Cell class	VIPR2 CALD1 ITLN1 PKHD1L1 PDPN FAT1 NLGN4X KCNT2	4.14e-07	180	167	8	1fa54bf4dba72866b2295639d991af639341bc08
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 KALRN RAPGEF5 KIAA1217 MACF1 ADGRF5 FYN IL4R	4.14e-07	180	167	8	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	ANK3 RAPGEF5 TACC2 CACHD1 ADGRV1 ADGRF5 ROS1 PCDH9	4.14e-07	180	167	8	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	TSPAN11 ANK3 TACC2 CACHD1 ADGRV1 KIAA1217 ADGRF5 ROS1	4.31e-07	181	167	8	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 RAPGEF5 AXL INPP4B DST KCNT2 MACF1 IL4R	4.89e-07	184	167	8	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	ANK3 RAPGEF5 TACC2 CACHD1 ADGRV1 ADGRF5 ROS1 PCDH9	4.89e-07	184	167	8	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ANK3 HS3ST5 TACC2 CACHD1 ADGRV1 KIAA1217 ADGRF5 ROS1	5.09e-07	185	167	8	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DENND2A FLT4 CALD1 KALRN RAPGEF5 PKHD1L1 PDPN MACF1	5.30e-07	186	167	8	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A RDH8 ACACB ANK3 OXR1 FRY KIAA1217 PCDH9	5.99e-07	189	167	8	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 TSPAN11 KALRN RAPGEF5 UNC5B PKHD1L1 PDPN ACKR3	6.23e-07	190	167	8	876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 TSPAN11 KALRN RAPGEF5 UNC5B PKHD1L1 PDPN ACKR3	6.23e-07	190	167	8	09a8855901c3c9332dbaab3e40166485b696d0f1
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	FLT4 CALD1 KALRN UNC5B PKHD1L1 PDPN ACKR3 VPS35L	6.23e-07	190	167	8	8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 TSPAN11 KALRN RAPGEF5 UNC5B PKHD1L1 PDPN ACKR3	6.23e-07	190	167	8	be9f36127028f52ca5fc1b32ba15a6c26aad69ac
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TSPAN11 CALD1 UNC5B FAT3 KLHL41 FBP2 FAT1 SNX7	6.48e-07	191	167	8	cc9a6a8fad17d6e1a08a68ab7512ae06b1249051
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	VIPR2 ANK3 RAPGEF5 AXL FAT3 INPP4B KCNT2 ADGRF5	6.48e-07	191	167	8	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TSPAN11 CALD1 UNC5B FAT3 KLHL41 FBP2 FAT1 SNX7	6.48e-07	191	167	8	c16b920ee69ea8536e020ac3475abf1ce972c1e6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 KALRN RAPGEF5 AXL INPP4B FRY KCNT2 ADGRF5	6.48e-07	191	167	8	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 KALRN RAPGEF5 AXL INPP4B FRY KCNT2 ADGRF5	6.48e-07	191	167	8	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 KALRN RAPGEF5 YES1 KIAA1217 ADGRF5 FYN IL4R	6.48e-07	191	167	8	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VIPR2 CALD1 KALRN ADAMTS8 INPP4B COL21A1 GRIP2 PCDH9	6.48e-07	191	167	8	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VIPR2 CALD1 KALRN AXL SORT1 FRY KCNT2 COL21A1	6.74e-07	192	167	8	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANK3 RAPGEF5 TACC2 CACHD1 ADGRV1 ADGRF5 ROS1 PCDH9	6.74e-07	192	167	8	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VIPR2 CALD1 KALRN AXL SORT1 FRY KCNT2 COL21A1	6.74e-07	192	167	8	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TSPAN11 UNC5B WNT4 FAT1 SNX7 ACKR3 KIAA1217 FGF1	7.01e-07	193	167	8	5e46a9f65e85aca78f825fdef88a95b97eec8743
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK3 RAPGEF5 TACC2 CACHD1 ADGRV1 ADGRF5 ROS1 PCDH9	7.01e-07	193	167	8	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK3 RAPGEF5 TACC2 CACHD1 ADGRV1 ADGRF5 ROS1 PCDH9	7.01e-07	193	167	8	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	ANK3 RAPGEF5 TACC2 CACHD1 ADGRV1 ADGRF5 ROS1 PCDH9	7.01e-07	193	167	8	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 FLT4 RAPGEF5 PKHD1L1 ADGRF5 GRIP2 FYN IL4R	7.01e-07	193	167	8	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	DENND2A FAT4 CALD1 FAT3 LAMC1 ADAMTS8 DST COL21A1	7.01e-07	193	167	8	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Adult-Endothelial\|Adult / Lineage, Cell type, age group and donor	FLT4 CALD1 KALRN RAPGEF5 UNC5B PKHD1L1 KIAA1217 FYN	7.29e-07	194	167	8	963b3fbee0575af8379baa397ace65949eaf34f7
ToppCell	Control-Endothelial\|Control / Disease state, Lineage and Cell class	FLT4 CALD1 KALRN RAPGEF5 PKHD1L1 PDPN KIAA1217 ADGRF5	7.29e-07	194	167	8	485fe5538fabec457b9a51feb641f2a91cbf4e18
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VIPR2 CALD1 KALRN AXL INPP4B FRY KCNT2 COL21A1	7.29e-07	194	167	8	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 KALRN RAPGEF5 UNC5B EHD4 ADGRF5 FYN IL4R	7.29e-07	194	167	8	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	DENND2A CALD1 FAT3 LAMC1 ADAMTS8 INPP4B DST COL21A1	7.58e-07	195	167	8	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	DENND2A CALD1 FAT3 LAMC1 ADAMTS8 INPP4B DST COL21A1	7.58e-07	195	167	8	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SEMA7A RAPGEF5 HS3ST5 DNAJC6 AATK FGF1 GRIP2 PCDH9	7.58e-07	195	167	8	1e28617ca55e5f318a228357737b968dfac8cca0
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DENND2A CALD1 FAT3 LAMC1 ADAMTS8 DST COL21A1 COL14A1	7.88e-07	196	167	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	Control-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	DENND2A FLT4 KALRN LAMC1 PKHD1L1 PDPN DST VPS35L	7.88e-07	196	167	8	e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4
ToppCell	Biopsy_Other_PF-Mesenchymal-Mesothelial_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	VIPR2 ITLN1 PKHD1L1 PHGDH PDPN NLGN4X KCNT2 FGF1	8.50e-07	198	167	8	86736f01e61bf4961f060b24ee1f1f48340737dd
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FAT4 CALD1 KALRN FAT3 DST COL21A1 MACF1 COL14A1	8.50e-07	198	167	8	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DENND2A ADAMTS8 PDPN DST COL21A1 MACF1 COL14A1 IL4R	8.83e-07	199	167	8	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	DENND2A FAT4 CALD1 FAT3 DST KCNT2 COL21A1 COL14A1	8.83e-07	199	167	8	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Biopsy_IPF-Mesenchymal-Mesothelial_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	VIPR2 CALD1 ITLN1 PKHD1L1 PDPN NLGN4X KCNT2 FGF1	9.17e-07	200	167	8	553386523fd8f8f36617a0d81032224b7ddce442
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANK3 RAPGEF5 DNAJC6 SORT1 AATK DST FGF1 PCDH9	9.17e-07	200	167	8	acdef0b9096c774040948fc75621ff2b08ea2ee8
ToppCell	COVID-19-kidney-Lymphatic_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 TSPAN11 KALRN UNC5B PKHD1L1 PDPN ACKR3	1.47e-06	148	167	7	f777aa1674e898e2594b2b7c029d3d05dda04df9
ToppCell	PND01-03-samps\|World / Age Group, Lineage, Cell class and subclass	SEMA7A RAPGEF5 UNC13D KLHL41 PDPN MDN1 ADGRF5	2.58e-06	161	167	7	1973b112d8d67aacc02751797d0148e7b53bfa66
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	ANK3 TACC2 CACHD1 ADGRV1 FAT1 KIAA1217 PCDH9	2.80e-06	163	167	7	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	Control-Epithelial-Mesothelial\|Control / Disease state, Lineage and Cell class	VIPR2 CALD1 ITLN1 PKHD1L1 PDPN FAT1 KCNT2	3.16e-06	166	167	7	1ed3788257e14f097862b999f020bfe2a57de52b
ToppCell	Endothelial-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DENND2A FLT4 TSPAN11 CALD1 KALRN PKHD1L1 PDPN	3.16e-06	166	167	7	c286987ea4e511195607c87ec4529c2c2ed2122e
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	DCHS2 FAT3 FBP2 ATP2C1 COL21A1 SCN8A COL14A1	3.16e-06	166	167	7	65dafed953b01a9830b54309af75c7a561e88336
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive\|lymph-node_spleen / Manually curated celltypes from each tissue	NAB2 NIBAN3 WDFY4 DAPP1 FGR PCDH9 PARP15	3.42e-06	168	167	7	494d5a11154ff22fedb25f4036d730cef376da60
ToppCell	BL-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FAT4 MUC19 KLHL41 WNT4 DST RPS6KA6 ADGRF5	3.70e-06	170	167	7	b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	CALD1 ANK3 TACC2 ADGRV1 DST KCNT2 ADGRF5	3.70e-06	170	167	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	Endothelial-B-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	DENND2A FLT4 TSPAN11 CALD1 PKHD1L1 PDPN VPS35L	3.85e-06	171	167	7	07ff7059071da83da1d8f266a586573920d75b58
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CALD1 KALRN FAT3 INPP4B LHCGR COL21A1 COL14A1	4.15e-06	173	167	7	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	TSPAN11 ANK3 MYO5A ADAMTS8 DNAJC6 NLGN4X KIAA1217	4.15e-06	173	167	7	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CALD1 KALRN AXL SORT1 FRY ACKR3 FGF1	4.48e-06	175	167	7	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 TSPAN11 KALRN UNC5B PKHD1L1 PDPN ACKR3	4.83e-06	177	167	7	66ffa279147961080c104242a08b176e301d80e3
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 TSPAN11 KALRN UNC5B PKHD1L1 PDPN ACKR3	4.83e-06	177	167	7	227d4f423b00be2e0c5797e2c5275d342e69a0f4
ToppCell	COVID-19-Heart-Lymph_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 TSPAN11 KALRN RAPGEF5 PKHD1L1 PDPN ACKR3	4.83e-06	177	167	7	326fde0734ef0d7272693966d346ca479b9d8147
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 TSPAN11 KALRN UNC5B PKHD1L1 PDPN ACKR3	4.83e-06	177	167	7	0cbf54608d2ba0a0500af142f2029fe5e118c3c2
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	DENND2A DCHS2 FLT4 TSPAN11 CALD1 KALRN PKHD1L1	5.01e-06	178	167	7	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	CALD1 AXL SORT1 FAT1 FGF1 COL14A1 IL4R	5.20e-06	179	167	7	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	5'-Adult-SmallIntestine-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TSPAN11 ANK3 ADAMTS8 NLGN4X COL21A1 GPR149 PCDH9	5.39e-06	180	167	7	5e6e38ee0758ef2342a6a821c78ed24b57bb7b11
ToppCell	moderate-Myeloid-pDC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	VIPR2 SEMA7A INPP4A NIBAN3 MDN1 NUP210 PCDH9	5.39e-06	180	167	7	1d8df7df03a71f49d6683554d3c948ce90dda42e
ToppCell	5'-Adult-SmallIntestine-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TSPAN11 ANK3 ADAMTS8 NLGN4X COL21A1 GPR149 PCDH9	5.39e-06	180	167	7	b88cd7ae922782176c057342d1b9eb9b8e5e7204
ToppCell	5'-Adult-SmallIntestine-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TSPAN11 ANK3 ADAMTS8 NLGN4X COL21A1 GPR149 PCDH9	5.39e-06	180	167	7	ebd6e719a03f25155fa8181be19469d04d6d10a6
ToppCell	RA-16._Neuronal\|RA / Chamber and Cluster_Paper	TSPAN11 ANK3 ADAMTS8 DNAJC6 NLGN4X COL21A1 KIAA1217	5.39e-06	180	167	7	5842febfdabac61ce970254fb0ef17a628f1b8c0
Drug	AC1L1KMJ	FLT4 ANK3 ACTB ACTG1 LAMC1 MFRP CLIP1 ADD1 DST COL21A1 PIK3R2 MACF1 COL14A1 MAPK8 FYN	2.46e-06	476	167	15	CID000030956
Drug	candesartan cilexetil	MYO5A ACTB ACTG1 MFRP LEP DST COL21A1 COL14A1	1.20e-05	145	167	8	CID000002540
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ATP6V1A FLT4 SORT1 LMAN1 IKBKE PLEKHA1 CABIN1 IL4R EDRF1	1.33e-05	193	167	9	3841_DN
Drug	Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A	GPR3 FLT4 C6orf62 ANK3 CEP162 NAB2 ZNF34 AATK LMAN1	1.38e-05	194	167	9	6555_DN
Drug	Iressa; Up 200; 10uM; HL60; HG-U133A	PCDHA9 ACACB ERAP1 INPP4A PHGDH TBC1D31 PIK3R2 DGCR8 FYN	1.44e-05	195	167	9	541_UP
Drug	Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	DENND2A FAT4 ACACB ANK3 NAB2 DNAJC6 ZNF34 VPS35L CABIN1	1.50e-05	196	167	9	5081_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A	PCDHA9 CEP162 SLC1A7 SORT1 PIK3R2 NUP210 PLAUR MAPK8 EDRF1	1.50e-05	196	167	9	5577_DN
Drug	Riboflavine [83-88-5]; Down 200; 10.6uM; PC3; HT_HG-U133A	GPR3 FAT4 CALD1 CEP162 AATK IKBKE PLEKHA1 DGCR8 IL4R	1.56e-05	197	167	9	4485_DN
Drug	Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; PC3; HT_HG-U133A	ACACB DSCAM ERAP1 CEP162 SLC1A7 ACKR3 FGF1 DGCR8 ABCC2	1.56e-05	197	167	9	4336_UP
Drug	Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A	RAD51D ANK3 CEP162 IPO9 LMAN1 PIK3R2 NUP210 CDK5RAP2 CABIN1	1.56e-05	197	167	9	4966_DN
Drug	Naproxen [22204-53-1]; Up 200; 17.4uM; PC3; HT_HG-U133A	GPR3 ACACB ERAP1 SLC1A7 ZNF34 MDN1 FGF1 MAPK8 CABIN1	1.56e-05	197	167	9	1828_UP
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	VIPR2 CEP162 NAB2 ARHGAP35 STARD5 IPO9 LMAN1 PIK3R2 CDK5RAP2	1.63e-05	198	167	9	7003_DN
Drug	ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A	FLT4 ANK3 DSCAM SEMA7A RAPGEF5 SLC1A7 PDPN AATK COL21A1	1.63e-05	198	167	9	6165_UP
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; PC3; HT_HG-U133A	GPR3 FLT4 ARHGAP35 SLC1A7 AATK COL21A1 FGF1 COL14A1 ABCC2	1.76e-05	200	167	9	6333_UP
Drug	D-myo-inositol-1,4,5-triphosphate	VIPR2 TRPM4 ANK3 DSG3 ACTB ACTG1 YES1 INPP4B ATP2C1 PIK3R2 FGF1 MAPK8 CABIN1 FYN KNG1	2.02e-05	568	167	15	CID000000806
Drug	NSC49633	MFRP DST COL21A1 COL14A1 ABCC2	4.32e-05	53	167	5	CID000023340
Drug	dithiobis(succinimidyl propionate	VIPR2 APOB SORT1 LHCGR PDPN	6.15e-05	57	167	5	CID000093313
Drug	4-hydroxy-2-nonenal	ATP6V1A ATR MARK3 NAB2 ACTB ACTG1 YES1 PHGDH DST TBC1D31 IKBKE PIK3R2 NUP210 FGR ABCC2 MAPK8 IL4R	8.38e-05	798	167	17	ctd:C027576
Drug	C75; Down 200; 10uM; PC3; HT_HG-U133A	DENND2A FLT4 DSCAM ERAP1 RAPGEF5 CEP162 BTN3A2 CABIN1	8.61e-05	191	167	8	6399_DN
Drug	Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A	RAD51D ATP6V1A FAT4 INPP4A CLIP1 LMAN1 CABIN1 FYN	9.26e-05	193	167	8	6704_DN
Drug	N6-methyladenosine [1867-73-8]; Up 200; 14.2uM; PC3; HT_HG-U133A	INPP4A SLC1A7 PDPN CPSF1 COL14A1 DGCR8 MAPK8 KNG1	9.26e-05	193	167	8	6732_UP
Drug	Fusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A	ANK3 DSCAM NAB2 CLIP1 LMAN1 MACF1 PLAUR CABIN1	9.59e-05	194	167	8	4105_DN
Drug	H-89, Dihydrochloride; Down 200; 0.5uM; PC3; HT_HG-U133A	ATP6V1A ANK3 ERAP1 AXL ACTB CLIP1 LMAN1 CABIN1	9.94e-05	195	167	8	6921_DN
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A	RAPGEF5 SLC1A7 ADD1 MDN1 FGF1 ADGRF5 DGCR8 CABIN1	9.94e-05	195	167	8	2125_DN
Drug	wartmannin	DNAJC13 MYO5A AXL ITLN1 ACTB ACTG1 YES1 LEP PIK3R4 PPP1R3A PIK3R2 RPS6KA6 FGF1 CDK5RAP2 MAPK8 FYN IL4R	1.02e-04	811	167	17	CID000005691
Drug	Phensuximide [86-34-0]; Up 200; 21.2uM; PC3; HT_HG-U133A	VIPR2 RDH8 FLT4 INPP4A NAB2 ARHGAP35 STARD5 CABIN1	1.03e-04	196	167	8	5097_UP
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ATP6V1A ARHGAP35 CLIP1 STARD5 SORT1 MACF1 CABIN1 EDRF1	1.03e-04	196	167	8	5425_DN
Drug	Acemetacin [53164-05-9]; Up 200; 9.6uM; PC3; HT_HG-U133A	SEMA7A ERAP1 RAPGEF5 INPP4A AATK IKBKE SCN8A FGF1	1.03e-04	196	167	8	6361_UP
Drug	Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A	VIPR2 TRPM4 FLT4 ACACB ERAP1 INPP4A DNAJC6 SLC1A7	1.03e-04	196	167	8	3187_DN
Drug	Cromolyn disodium salt [15826-37-6]; Down 200; 7.8uM; PC3; HT_HG-U133A	CALD1 CTC1 ARHGAP35 CLIP1 ACKR3 FGF1 CABIN1 FYN	1.03e-04	196	167	8	5754_DN
Drug	Xylazine [7361-61-7]; Up 200; 18.2uM; PC3; HT_HG-U133A	VIPR2 DCHS2 CALD1 KALRN DSG3 TNS4 DGCR8 SAGE1	1.03e-04	196	167	8	4066_UP
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; PC3; HT_HG-U133A	CALD1 DSCAM RAPGEF5 CEP162 NAB2 ARHGAP35 DNAJC6 IKBKE	1.03e-04	196	167	8	6305_UP
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	SEMA7A CEP162 ARHGAP35 ADD1 LMAN1 PIK3R2 IL4R EDRF1	1.03e-04	196	167	8	2312_DN
Drug	Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	VIPR2 INPP4A SORT1 IKBKE PIK3R2 DGCR8 CABIN1 EDRF1	1.07e-04	197	167	8	5459_DN
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A	VIPR2 ACACB INPP4A NAB2 SORT1 DAPP1 IL4R EDRF1	1.07e-04	197	167	8	3629_DN
Drug	Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A	FLT4 CTC1 INPP4A NAB2 ARHGAP35 IKBKE NUP210 EDRF1	1.07e-04	197	167	8	4354_DN
Drug	Panthenol (D) [81-13-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A	UNC5B ARHGAP35 ZNF34 IPO9 LMAN1 IKBKE MAPK8 PCDH9	1.07e-04	197	167	8	1680_UP
Drug	HNMPA-(AM)3; Down 200; 5uM; PC3; HG-U133A	GPR3 RAPGEF5 STARD5 FEZ2 CPSF1 FGF1 TNS4 DGCR8	1.07e-04	197	167	8	583_DN
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	CTC1 ARHGAP35 ZNF34 MDN1 NUP210 CDK5RAP2 MACF1 CABIN1	1.07e-04	197	167	8	5482_DN
Drug	Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A	RAD51D GPR3 TRPM4 DSCAM INPP4A CEP162 IKBKE FGF1	1.11e-04	198	167	8	3666_DN
Drug	Reserpinic acid hydrochloride; Up 200; 9.2uM; PC3; HT_HG-U133A	PCDHA9 ACACB SEMA7A INPP4A NAB2 ADD1 FGF1 ADGRF5	1.11e-04	198	167	8	6603_UP
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; PC3; HT_HG-U133A	RAD51D ANK3 SEMA7A STARD5 ZNF34 AATK NUP210 FGF1	1.14e-04	199	167	8	4209_DN
Drug	Nifurtimox [23256-30-6]; Up 200; 14uM; PC3; HT_HG-U133A	VIPR2 PCDHA9 KALRN DSG3 RAPGEF5 INPP4A SORT1 FGF1	1.14e-04	199	167	8	6608_UP
Drug	Ergocryptine-alpha [511-09-1]; Down 200; 7uM; PC3; HT_HG-U133A	RAD51D INPP4A NAB2 ARHGAP35 IKBKE NUP210 SLC12A7 IL4R	1.14e-04	199	167	8	4552_DN
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	GPR3 PCDHA9 ARHGAP35 PDPN LMAN1 DGCR8 ABCC2 EDRF1	1.14e-04	199	167	8	3684_DN
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A	DSCAM INPP4A CEP162 UNC5B PDPN DGCR8 ABCC2 PCDH9	1.14e-04	199	167	8	3696_DN
Drug	Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	RAD51D VIPR2 FLT4 SLC1A7 IKBKE PLAUR CABIN1 IL4R	1.14e-04	199	167	8	6075_DN
Drug	methenamine silver	ACTB ACTG1 APOB CLIP1 VILL IKBKE DIAPH3 MAPK8	1.23e-04	201	167	8	CID000004101
Drug	Triglycerides	APOB LEP SORT1 DGAT2 KNG1	1.24e-04	66	167	5	ctd:D014280
Drug	4-chloroaniline	REG4 CALD1 NAB2 ACTB ACTG1 SORT1 PDPN ACKR3	1.27e-04	202	167	8	CID000007812
Drug	LY294002	FLT4 MYO5A AXL CEP162 ACTB ACTG1 YES1 LEP SORT1 PIK3R4 PIK3R2 RPS6KA6 FGF1 CDK5RAP2 MAPK8 FYN	1.30e-04	748	167	16	CID000003973
Drug	GK-101	MFRP DST COL21A1 COL14A1	1.37e-04	36	167	4	CID000161853
Drug	2,4,5-Trichlorophenoxyacetic Acid	CAPN6 TACC2 PPP1R3A IKBKE SNX7 ABCC2	1.40e-04	107	167	6	ctd:D015085
Disease	neutrophil count, basophil count	TET2 PCDHA9 PCDHA7 PCDHA4 EHD4 TRAP1 ACKR3 PLAUR PXYLP1 SLC12A7	5.51e-07	224	164	10	EFO_0004833, EFO_0005090
Disease	Moyamoya disease (implicated_via_orthology)	ACTB ACTG1 POTEKP	9.25e-06	8	164	3	DOID:13099 (implicated_via_orthology)
Disease	autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology)	ACTB ACTG1 POTEKP	9.25e-06	8	164	3	DOID:0110550 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome 1 (implicated_via_orthology)	ACTB ACTG1 POTEKP	9.25e-06	8	164	3	DOID:0081112 (implicated_via_orthology)
Disease	thoracic aortic aneurysm (implicated_via_orthology)	ACTB ACTG1 POTEKP	9.25e-06	8	164	3	DOID:14004 (implicated_via_orthology)
Disease	granulocyte count	TET2 REG4 ITLN1 EHD4 TRAP1 ACKR3 PLAUR PXYLP1 SLC12A7	1.34e-05	254	164	9	EFO_0007987
Disease	1,5 anhydroglucitol measurement	PCDHA9 PCDHA7 PCDHA4 PKD1L2	1.96e-05	29	164	4	EFO_0008009
Disease	intestinal atresia (implicated_via_orthology)	ACTB ACTG1 POTEKP	1.97e-05	10	164	3	DOID:10486 (implicated_via_orthology)
Disease	patent ductus arteriosus (implicated_via_orthology)	ACTB ACTG1 POTEKP	1.97e-05	10	164	3	DOID:13832 (implicated_via_orthology)
Disease	carcinoma (implicated_via_orthology)	FAT4 FLT4 YES1 FGR FYN	2.92e-05	64	164	5	DOID:305 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome	ACTB ACTG1	3.07e-05	2	164	2	cv:C1853623
Disease	Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation	ACTB ACTG1	3.07e-05	2	164	2	C1855722
Disease	Fryns-Aftimos Syndrome	ACTB ACTG1	3.07e-05	2	164	2	C1853623
Disease	age-related macular degeneration, disease progression measurement	TSPAN11 SNX7 ACKR3 PCDH9	7.94e-05	41	164	4	EFO_0001365, EFO_0008336
Disease	Colorectal Carcinoma	TET2 KALRN CAPN6 LAMC1 APOB SLC1A7 FAT1 NLGN4X ACKR3 TNS4 ABCC2 EDRF1 ANAPC4	1.60e-04	702	164	13	C0009402
Disease	Prostatic Neoplasms	TET2 TRPM4 ATR LAMC1 UNC13D ADAMTS8 WNT4 LEP PHGDH PIK3R2 PLAUR MED12	1.81e-04	616	164	12	C0033578
Disease	Malignant neoplasm of prostate	TET2 TRPM4 ATR LAMC1 UNC13D ADAMTS8 WNT4 LEP PHGDH PIK3R2 PLAUR MED12	1.81e-04	616	164	12	C0376358
Disease	vital capacity	TET2 DENND2A PCDHA9 HYKK CEP162 UNC5B ACTG1 PCDHA7 UNC13D PCDHA4 APOB ADAMTS8 WNT4 SENP1 DST COL21A1 DIAPH3 ANAPC4	1.88e-04	1236	164	18	EFO_0004312
Disease	neutrophil count, eosinophil count	TET2 EHD4 TRAP1 ACKR3 PLAUR PXYLP1 SLC12A7	1.98e-04	213	164	7	EFO_0004833, EFO_0004842
Disease	epilepsy (implicated_via_orthology)	KALRN SLC1A7 KCNK18 KCNT2 SCN8A SLC12A7	3.11e-04	163	164	6	DOID:1826 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	CATSPERE KALRN TACC2 CLIP1 BTN3A2 LEP PHGDH INPP4B PIK3R4 PPP1R3A LHCGR KCNT2 ACCS MACF1 BOD1L1 MED12	3.39e-04	1074	164	16	C0006142
Disease	neuroticism measurement, cognitive function measurement	TET2 PCDHA9 DSCAM KALRN PCDHA7 PCDHA4 AATK KIAA1217 PLEKHA1 PCDH9 ANAPC4	3.44e-04	566	164	11	EFO_0007660, EFO_0008354
Disease	Liver Cirrhosis, Experimental	MYO5A ERAP1 HYKK AXL LEP FRY FAT1 SNX7 ACKR3 FGR ABCC2 FYN KNG1	4.09e-04	774	164	13	C0023893
Disease	non-alcoholic fatty liver disease (biomarker_via_orthology)	ACACB LEP DGAT2 MAPK8	4.78e-04	65	164	4	DOID:0080208 (biomarker_via_orthology)
Disease	Nonorganic psychosis	ANK3 LEP DGCR8 MED12	6.00e-04	69	164	4	C0349204
Disease	colorectal cancer (implicated_via_orthology)	YES1 FGR FYN	6.13e-04	30	164	3	DOID:9256 (implicated_via_orthology)
Disease	Uveoretinal Coloboma	ACTB ACTG1	6.33e-04	7	164	2	C4554007
Disease	temporal lobe epilepsy (biomarker_via_orthology)	ACTB ADD1 FYN	6.76e-04	31	164	3	DOID:3328 (biomarker_via_orthology)
Disease	fatty liver disease (implicated_via_orthology)	ACACB LEP DGAT2	6.76e-04	31	164	3	DOID:9452 (implicated_via_orthology)
Disease	Large cell carcinoma of lung	ATR RPS6KA6 ROS1	7.43e-04	32	164	3	C0345958
Disease	intestinal cancer (implicated_via_orthology)	YES1 FGR FYN	7.43e-04	32	164	3	DOID:10155 (implicated_via_orthology)
Disease	pulse pressure measurement	TET2 PCDHA9 DSCAM MARK3 FAT3 CELA2A PCDHA7 UNC13D PCDHA4 ADAMTS8 CELA2B YES1 PIK3R4 SENP1 ZNF827 COL21A1 KIAA1217 FGR	7.70e-04	1392	164	18	EFO_0005763
Disease	fatty liver disease (biomarker_via_orthology)	APOB LEP ABCC2	8.14e-04	33	164	3	DOID:9452 (biomarker_via_orthology)
Disease	nemaline myopathy (implicated_via_orthology)	ACTB KLHL41	8.41e-04	8	164	2	DOID:3191 (implicated_via_orthology)
Disease	abdominal fat cell number	DNAJC13 RAPGEF5 INPP4B KIAA1217 DIAPH3 KCTD18	8.67e-04	198	164	6	EFO_0021534
Disease	optic disc size measurement	DENND2A TSPAN11 MARK3 HS3ST5 ADAMTS8 MACF1	1.04e-03	205	164	6	EFO_0004832
Disease	Congenital ocular coloboma (disorder)	ACTB ACTG1	1.08e-03	9	164	2	C0009363
Disease	lean body mass	TET2 ADGRV1 AATK IPO9 SLF2 PRIM1 PLEKHA1 DIAPH3	1.32e-03	379	164	8	EFO_0004995
Disease	cardiovascular system disease (is_marker_for)	APOB PLAUR	1.34e-03	10	164	2	DOID:1287 (is_marker_for)
Disease	Congenital neurologic anomalies	ACTB ACTG1	1.34e-03	10	164	2	C0497552
Disease	Peripheral T-Cell Lymphoma	TET2 FYN	1.34e-03	10	164	2	C0079774
Disease	Cranioschisis	ACTB ACTG1	1.34e-03	10	164	2	C0265541
Disease	vascular endothelial growth factor receptor 3 measurement	FLT4 KNG1	1.34e-03	10	164	2	EFO_0008315
Disease	Stomach Neoplasms	FAT4 REG4 ATR TRAP1 CPSF1 MAPK8 FYN	1.42e-03	297	164	7	C0038356
Disease	Abnormality of refraction	VIPR2 DNAJC13 PCDHA9 ANK3 DSCAM FAT3 PCDHA7 PCDHA4 PIK3R4 FRY PCDH9	1.42e-03	673	164	11	HP_0000539
Disease	cortical thickness	MARK3 FAT3 LAMC1 CPA3 TACC2 ADAMTS8 ADGRV1 ARHGAP35 CLYBL COL21A1 ACKR3 CDK5RAP2 MACF1 DIAPH3 USP15	1.43e-03	1113	164	15	EFO_0004840
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	TET2 FLT4 INPP4B MAPK8 IL4R	1.46e-03	148	164	5	C0279702
Disease	Malignant neoplasm of stomach	FAT4 REG4 ATR TRAP1 CPSF1 MAPK8 FYN	1.50e-03	300	164	7	C0024623
Disease	kidney disease (implicated_via_orthology)	YES1 FGR FYN	1.54e-03	41	164	3	DOID:557 (implicated_via_orthology)
Disease	rectum cancer	LAMC1 WDFY4 INPP4B	1.65e-03	42	164	3	EFO_1000657
Disease	Squamous cell carcinoma of esophagus	FAT4 FAT3 FAT1 ABCC2	1.98e-03	95	164	4	C0279626
Disease	esophagus squamous cell carcinoma (is_implicated_in)	TET2 FAT1 COL14A1	2.02e-03	45	164	3	DOID:3748 (is_implicated_in)
Disease	uric acid measurement	TET2 FAT4 FLT4 DNAJC13 REG4 DSCAM FAT3 ADGRV1 ZNF827 ANAPC4	2.27e-03	610	164	10	EFO_0004761
Disease	Major Depressive Disorder	KALRN RAPGEF5 USP46 LEP IKBKE MED12	2.45e-03	243	164	6	C1269683
Disease	Psychotic Disorders	ANK3 LEP DGCR8 MED12	2.47e-03	101	164	4	C0033975
Disease	platelet crit	TET2 DENND2A KALRN ERAP1 APOB ADGRV1 YES1 EHD4 SENP1 PRIM1 PLAUR SLC12A7 USP15	2.64e-03	952	164	13	EFO_0007985
Disease	type 2 diabetes mellitus (is_implicated_in)	AXL APOB LEP PPP1R3A MAPK8	2.73e-03	171	164	5	DOID:9352 (is_implicated_in)
Disease	coronary artery disease	TET2 FAT4 DNAJC13 DSCAM MARK3 LAMC1 UNC13D APOB SENP1 ZNF827 GPR149 KIAA1217 NUP210 CABIN1 FYN	2.80e-03	1194	164	15	EFO_0001645
Disease	type 2 diabetes mellitus (implicated_via_orthology)	ADAMTS8 LEP PPP1R3A MAPK8	2.84e-03	105	164	4	DOID:9352 (implicated_via_orthology)
Disease	pancreatic carcinoma	MARK3 APOB DST ACKR3 TNS4	2.94e-03	174	164	5	EFO_0002618
Disease	platelet component distribution width	DENND2A FLT4 KALRN MARK3 INPP4B DGAT2 DAPP1 MACF1 ADGRF5 SLC12A7 USP15	3.43e-03	755	164	11	EFO_0007984
Disease	cortical surface area measurement	TET2 DCHS2 DNAJC13 ANK3 RAPGEF5 CEP162 FAT3 LAMC1 CPA3 CACHD1 WNT4 ADGRV1 ACKR3 VPS35L MACF1 DIAPH3	3.48e-03	1345	164	16	EFO_0010736
Disease	Tremor, Rubral	UROC1 SCN8A	3.50e-03	16	164	2	C0750940
Disease	Ataxia, Appendicular	UROC1 SCN8A	3.50e-03	16	164	2	C0750937
Disease	Ataxia, Motor	UROC1 SCN8A	3.50e-03	16	164	2	C0278161
Disease	Ataxia, Sensory	UROC1 SCN8A	3.50e-03	16	164	2	C0240991
Disease	Abnormal coordination	UROC1 SCN8A	3.50e-03	16	164	2	C0520966
Disease	Ataxia, Truncal	UROC1 SCN8A	3.50e-03	16	164	2	C0427190
Disease	forced expiratory volume, response to bronchodilator	TET2 TSPAN11 OXR1 HYKK UROC1 ADGRV1 KCNT2 ACKR3	3.56e-03	445	164	8	EFO_0004314, GO_0097366
Disease	mean corpuscular hemoglobin concentration	DNAJC13 ATR KALRN MARK3 AXL ACTB PHGDH KIAA1217 PRIM1 MACF1 ADGRF5 SLC12A7 FYN LRIF1	3.57e-03	1105	164	14	EFO_0004528
Disease	creatinine measurement	TET2 DNAJC13 DSCAM SEMA7A INPP4A CELA2B ADGRV1 SLC1A7 PPP1R3A FRY SLF2 USP32 KNG1	3.83e-03	995	164	13	EFO_0004518
Disease	cancer (implicated_via_orthology)	FLT4 YES1 DST MACF1 FGR FYN	3.96e-03	268	164	6	DOID:162 (implicated_via_orthology)
Disease	Hypertensive disease	ERAP1 CELA2A LEP ADD1 KNG1	4.28e-03	190	164	5	C0020538
Disease	adverse effect, response to xenobiotic stimulus	CENPC EHD4 COL14A1	4.36e-03	59	164	3	EFO_0009658, GO_0009410
Disease	urate measurement	DNAJC13 RAPGEF5 MARK3 CELA2B ADGRV1 BTN3A2 PHGDH INPP4B TRAP1 ZNF827 DGAT2 ANAPC4	4.42e-03	895	164	12	EFO_0004531
Disease	Tachycardia	LEP KNG1	4.43e-03	18	164	2	C0039231
Disease	Malignant neoplasm of endometrium	ATR PIK3R2	4.43e-03	18	164	2	C0007103
Disease	Tachyarrhythmia	LEP KNG1	4.43e-03	18	164	2	C0080203
Disease	caudal middle frontal gyrus volume measurement	FBP2 FRY	4.43e-03	18	164	2	EFO_0010290
Disease	Carcinoma in situ of endometrium	ATR PIK3R2	4.43e-03	18	164	2	C0346191
Disease	non-alcoholic fatty liver disease (is_implicated_in)	DGAT2 ABCC2	4.43e-03	18	164	2	DOID:0080208 (is_implicated_in)
Disease	body weight	TET2 ADGRV1 CLIP1 BTN3A2 PPP1R3A LHCGR AATK IPO9 TBC1D31 FEZ2 KIAA1217 PLEKHA1 PXYLP1 FGR ANAPC4	4.63e-03	1261	164	15	EFO_0004338
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	ACACB APOB BTN3A2 MACF1 PLAUR	5.31e-03	200	164	5	EFO_0004611, EFO_0020945
Disease	Bipolar Disorder	VIPR2 ANK3 DSCAM RAPGEF5 ACTB USP46 SCN8A FYN	5.37e-03	477	164	8	C0005586
Disease	Headache	GPR149 PLEKHA1 MACF1	5.48e-03	64	164	3	HP_0002315

Protein segments in the cluster

Peptide	Gene	Start	Entry
LDGKTTISSTSEYER	BDP1	1811	A6H8Y1
NILKGVRDSSYSLES	C6orf62	66	Q9GZU0
GSFTYATTEKVRRSI	ANAPC4	621	Q9UJX5
RIFSTRSTIKLEYEG	CATSPERE	31	Q5SY80
IRESEYSSSLGILAS	CTC1	1201	Q2NKJ3
LSVFEKSVGYRSVLS	ACCS	291	Q96QU6
GTILKYSGSIATLER	ADAMTS8	761	Q9UP79
KILTERGYRFTTTAE	POTEKP	191	Q9BYX7
KILTERGYSFTTTAE	ACTB	191	P60709
KILTERGYSFTTTAE	ACTG1	191	P63261
SSTGILTLAKALDYE	FAT4	3141	Q6V0I7
RITTEGVEDSYKGAT	ADGRV1	3741	Q8WXG9
IIYLSAGITSKDSSE	CACHD1	341	Q5VU97
YVAESGSLAVSVSKI	CELA2A	91	P08217
ISIEDSRVYELTSKA	DGCR8	601	Q8WYQ5
STVKETRAEGYFISI	DIAPH3	426	Q9NSV4
TAVAIASRLGLYSKT	ATP2C1	576	P98194
IGATSSKETLDILYA	CLYBL	211	Q8N0X4
SSVSTAKLTLEEAYR	CDK5RAP2	1781	Q96SN8
LYEELKTSTAILSTG	RAD51D	71	O75771
LYTGEISTTRALDET	PCDHA9	626	Q9Y5H5
SEGTKAVLRTSLYAI	H2BW1	156	Q7Z2G1
SLTEALGIRSKYASL	INPP4A	201	Q96PE3
STALTGYTLLTSQRE	NIBAN3	146	Q86XR2
ISLYKEVTDSRSGNI	ACACB	1661	O00763
EVVEVLSGYKSLTSL	MFRP	496	Q9BY79
LYTGEISTTRALDET	PCDHA7	626	Q9UN72
KAEAQGSTTLLVSYR	NUP210	611	Q8TEM1
VLAIDEYTGKTSTGT	DSG3	466	P32926
DSSTGLISLLRTLDY	FAT1	2336	Q14517
KLILSEVFEYSSSTR	PARP15	221	Q460N3
GYSSSREITEAAVLL	ITLN1	296	Q8WWA0
TGDILATILSTSYNR	KCNK18	151	Q7Z418
TSLVEYLAAVTGRTK	MDN1	336	Q9NU22
GLESIQRLIATSSYS	LHCGR	241	P22888
YFLTRTVDTSEKGRV	LRIF1	106	Q5T3J3
RESETTKGAYSLSIR	FGR	171	P09769
ARESTYLSSLKGSRL	NAB2	351	Q15742
ASGSDIVKLYDLTTL	EDRF1	426	Q3B7T1
SSVYSKGRILTTEQT	DST	481	Q03001
YQDILTELSKETGSS	INPP4B	311	O15327
ARTSLLYLSSSLGTE	IKBKE	461	Q14164
VSLRSEETVSGLKGY	CPSF1	1106	Q10570
DSLTSLIYGEQSEKT	TMEM63C	76	Q9P1W3
ASIGTIFAIYRKTSE	FBP2	131	O00757
TYRTKEGELRILAST	ERAP1	166	Q9NZ08
TTRAISDYTQVLEGK	HS3ST5	186	Q8IZT8
YSVEIGDSTFTVLKR	MAPK8	11	P45983
SSSYLLGRDKVVSVF	OR5A1	266	Q8NGJ0
SEVTETTGLSYGVKR	MUC19	3431	Q7Z5P9
TGTSASLVYRLVSKA	PCDH9	56	Q9HC56
YTVSSCDSGEITLKI	KALRN	2521	O60229
ERSSISLVSLAGSLY	KLHL41	531	O60662
EASGYSTEVVALSRL	LEP	136	P41159
RYVSSLTEEISKRGA	LMAN1	361	P49257
SIFTYGTSQKTEREL	MAT1A	331	Q00266
ELLLKSSDLVGSYTT	MED12	906	Q93074
STGKTTFIRYLLEQD	EHD4	71	Q9H223
TLSNLARKEYTVGET	ABCC2	406	Q92887
SEREASDILYVISKT	RPS6KA6	516	Q9UK32
SVLKTDAEELVSRSY	MICU3	296	Q86XE3
IGIYRTESQKLTTSE	KCNT2	956	Q6UVM3
TASIGSLLAITVDRY	GPR3	121	P46089
LDGIKTRYADITVTS	MACF1	5536	Q9UPN3
TLKTVDSSGSLYVRT	RDH8	266	Q9NYR8
TSSKVTVTLYGLDGE	PKD1L2	1406	Q7Z442
SGVITTKAILDYELT	DCHS2	2296	Q6V1P9
EAGTAYIIKTTSEST	PPP1R3A	726	Q16821
KTLSLSTYEVSAEGQ	GPR149	566	Q86SP6
SVSGEVSILKSLDYE	PCDHGA3	296	Q9Y5H0
KLSSAVRSGIVEYLS	PRIM1	176	P49642
KGTIEYTVESRDSLN	OXR1	96	Q8N573
LYTGEISTTRALDET	PCDHA4	626	Q9UN74
DASSKIQGEYTLTLR	PIK3R2	356	O00459
ESRIIGVYATKTDGT	KCTD18	156	Q6PI47
ETKRDYSTELSVTIA	NLGN4Y	666	Q8NFZ3
GITLQRRSESYSEDK	BOD1L1	861	Q8NFC6
ILRVNDESTEGKTSY	APOB	1076	P04114
YRKETSESTDLQTTL	ATR	1271	Q13535
IAASTLKSGISYRAR	IL4R	186	P24394
SVDSGSEIKSYLVRL	HYKK	111	A2RU49
AKIGTDVLSTRYETR	CPA3	331	P15088
LDKVSAYIEGTSTEV	CABIN1	1026	Q9Y6J0
DAKTSSRLGVLTVAY	SLC1A7	81	O00341
YVAESGSLAVSVSKI	CELA2B	91	P08218
TKLGLTRTLSEENVY	DENND2A	356	Q9ULE3
SDKTVLDTSYALIGE	CENPC	376	Q03188
IKYVRDTLFTAESGT	COL14A1	1116	Q05707
RESETTKGAYSLSIR	FYN	176	P06241
TTGLYSLSVRAKDSV	DAPP1	66	Q9UN19
GVITTQKALDYERTS	FAT3	1721	Q8TDW7
RVIQSVTSYTKGDLD	DNAJC6	51	O75061
GYEVTSKVDLSELTS	COL21A1	256	Q96P44
TKLIDASRVSETEYS	ACKR3	341	P25106
TKVIDYLTNDIGSSS	ANK3	2031	Q12955
ARLEKGLTSSIDYSR	CEP162	136	Q5TB80
KIQYLTRGEESSSDT	BTN3A2	316	P78410
GQVRKYSSTERDSLL	DNAJC13	301	O75165
EITATYLLLGRKSSE	MARK3	356	P27448
GLRESISKVRSSVAY	IPO9	116	Q96P70
LTSIKIRGTYSERSA	LAMC1	651	P11047
LYRITEATKTVGSDT	KNG1	56	P01042
VESLYDTTLELSSRK	FRY	341	Q5TBA9
ELETTGAVSYTVELK	GRIP2	646	Q9C0E4
GTSTYIDTRTVFLSK	CAPN6	446	Q9Y6Q1
LIAEKYRSRDTSLSG	SLC12A7	986	Q9Y666
ETKRDYSTELSVTIA	NLGN4X	666	Q8N0W4
LTETSSRYARKISGT	CLIP1	336	P30622
VSRDTIDYLLSKNGS	DGAT2	216	Q96PD7
TGSYEERVKRLSVSE	FEZ2	206	Q9UHY8
LSLKEASTIAEYISG	REG4	71	Q9BYZ8
SRFLITSTGALYIKD	DSCAM	171	O60469
IFTSDDRGIVYSKSL	SORT1	376	Q99523
ESSSILYKVFAVTRD	TBC1D31	211	Q96DN5
LTVTETSRGLNFEYK	AATK	466	Q6ZMQ8
TGILSLSNVSKRTEY	RGS22	826	Q8NE09
SEDRYKSGLTTLVAT	PDPN	56	Q86YL7
LSAESVGEVYIKSTE	FGF1	61	P05230
RSLYLETRKTSSGLS	SENP1	116	Q9P0U3
SVDSLLSDRYVVVSG	RAPGEF5	61	Q92565
ISDASRTSEYKTEII	KIAA1217	1226	Q5T5P2
YLETTGKSRTLQSGL	PXYLP1	201	Q8TE99
EDYLVSETQTTSRGK	SLF2	881	Q8IX21
LSYVVESIEKSREST	ARHGAP35	671	Q9NRY4
TYRIITKTSRGEFDS	SNX7	51	Q9UNH6
RYLDGAESVLTVKTS	ADGRF5	521	Q8IZF2
DSRLEQYTSAIEGTK	CALD1	676	Q05682
GLLYSEVTASSLVKI	ADD1	186	P35611
EGKTTTTRSILTYSR	PIK3R4	1026	Q99570
TLSYRTGLKITSLTE	PLAUR	76	Q03405
RGEILARYTTTEKLS	VPS35L	121	Q7Z3J2
AAAGISSTITRDLYV	SAGE1	656	Q9NXZ1
YLSSVSVETLTGALA	TNS4	586	Q8IZW8
SSRTEYEKLFALGVT	UROC1	186	Q96N76
LVKRYEDGTISSNAT	STARD5	121	Q9NSY2
IKARIEGTTAASSYV	FLT4	116	P35916
LKEVTEASTGTYTLA	FLT4	386	P35916
LKSVYVLTGTDSETL	WDFY4	141	Q6ZS81
IAIESLADRVYTSKS	AXL	716	P30530
RYVKISTETEETEGS	USP15	616	Q9Y4E8
TTSGIGSSVEKYIID	SCN8A	1066	Q9UQD0
VYSLGDIDKVFRTSS	SEMA7A	336	O75326
AAREASIYTGITLSE	ATP6V1A	321	P38606
LYSVESTRLNGESSL	ROS1	806	P08922
TDVSISKTALYSRIG	TACC2	2716	O95359
SKTALYSRIGTAEVE	TACC2	2721	O95359
LDLVRTKYTGTNVSL	PKHD1L1	796	Q86WI1
SSILYARKDSSSVVE	TBC1D15	61	Q8TC07
TLVEKSGYLSVLASS	TSPAN11	41	A1L157
VFTGESYSRSAVKRL	UNC5B	681	Q8IZJ1
SISEKARGLALTYSL	VILL	181	O15195
VLVKDDVLYSSSGTL	VIPR2	176	P41587
KEGESLSTTLPRSSY	ZNF827	601	Q17R98
LTSDISKNSESGYIL	USP46	346	P62068
QSSLTEIKGSVYETT	ZUP1	136	Q96AP4
SRELGSSVALYSRKV	TRAP1	356	Q12931
LYLAKLSSVGSISEE	WNT4	26	P56705
RLLSYQTSLVSDGET	PHGDH	491	O43175
SGSSRVGAIKLTYIS	PLEKHA1	51	Q9HB21
SELTETLRKYGTLTN	TET2	1246	Q6N021
SSVYAEVSRLLLATG	TTL	11	Q8NG68
RLSKDVTYSVLTDGA	WDR87	851	Q6ZQQ6
YSLSSGTTEEELLRK	THAP11	246	Q96EK4
TTSEELGAVTVKASY	UNC13D	906	Q70J99
TRKELLTVYSSEDGS	TRPM4	356	Q8TD43
RIGSSLSYVNTTEEK	USP32	446	Q8NFA0
LGTRTEYKELTSQET	ZNF34	116	Q8IZ26
IFLVRESETTKGAYS	YES1	181	P07947
LRKRTSSIADEGTYT	MYO5A	1646	Q9Y4I1